Literature for inhibitor I04.001: alpha-1-peptidase inhibitor

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature

(Topics flags: S Structure, P Specificity, K Knockout, E Expression, V Review, M Mutation, I Inhibitor, U Therapeutic. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Abdulkarim,A. and Craig,T.J.
    Alpha 1 Antitrypsin Mutation
    PubMed  Europe PubMed
  2. Boyle,L.D., Miguelez-Crespo,A., Paul,M., Villalobos,E., Toews,J.N.C., Ivatt,L., Nagy,B., Magennis,M., Homer,N.Z.M., Andrew,R., Viau,V., Hammond,G.L., Stimson,R.H., Walker,B.R. and Nixon,M.
    The NE/AAT/CBG axis regulates adipose tissue glucocorticoid exposure
    Nat Commun16, 545-545. PubMed  Europe PubMed DOI
  3. Elshikha,A.S., Abboud,G., Avdiaj,R., Morel,L. and Song,S.
    The Inhibitory Effects of Alpha 1 Antitrypsin on Endosomal TLR Signaling Pathways
    Biomolecules15, PubMed  Europe PubMed DOI
  4. Engelmaier,A., Zimmermann,M., Butterweck,H.A. and Weber,A.
    Clinical Study Support by Long-Term Stability Studies of Alpha(1)-Proteinase Inhibitor and Urea in Relevant Biological Matrices
    Pharmaceuticals (Basel)18, PubMed  Europe PubMed DOI
  5. Fromme,M., Klebingat,F., Ellis,P. and Strnad,P.
    Alpha-1 antitrypsin deficiency-associated liver disease: From understudied disorder to the poster child of genetic medicine
    Hepatol Commun9, PubMed  Europe PubMed DOI  V
  6. Gordon,M., Gangemi,A.J., Sandwith,E.L., Kumaran,M. and Kueppers,F.
    Vascular Pathology in Alpha 1 Antitrypsin Deficient Chronic Obstructive Pulmonary Disease and Emphysema Patients: Case Reports
    Appl Clin Genet18, 1-7. PubMed  Europe PubMed DOI
  7. Huntington,J.A., Reckless,J., Polderdijk,S.G.I., Hextall,P. and Baglin,T.
    The preclinical profile of SerpinPC- a potential new treatment for hemophilia
    Blood Adv PubMed  Europe PubMed DOI
  8. Wang,T., Shuai,P., Wang,Q., Guo,C., Huang,S., Li,Y., Wu,W. and Yi,L.
    alphaƒ_'1 Antitrypsin is a potential target of inflammation and immunomodulation (Review)
    Mol Med Rep31, PubMed  Europe PubMed DOI
  9. Xiang,S., Yang,L., He,Y., Ding,F., Qiao,S., Su,Z., Chen,Z., Lu,A. and Li,F.
    Alpha-1 Antitrypsin as a Regulatory Protease Inhibitor Modulating Inflammation and Shaping the Tumor Microenvironment in Cancer
    Cells14, PubMed  Europe PubMed DOI  V
  10. 2024
  11. Bai,X., Gao,J., Guan,X., Narum,D.E., Fornis,L.B., Griffith,D.E., Gao,B., Sandhaus,R.A., Huang,H. and Chan,E.D.
    Analysis of alpha-1-antitrypsin (AAT)-regulated, glucocorticoid receptor-dependent genes in macrophages reveals a novel host defense function of AAT
    Physiol Rep12, e16124-e16124. PubMed  Europe PubMed DOI
  12. Balduyck,M., Afif,S., Onraed,B., Jourdain,M., Nseir,S., Pigny,P. and Zerimech,F.
    Does hypersialylation compensate the functional Alpha1-AntiTrypsin (A1AT) deficiency in all critically ill patients?
    Biochimie PubMed  Europe PubMed DOI
  13. Chen,C.H., Crisford,H., Scott,A., Sapey,E. and Stockley,R.A.
    A novel in vitro cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency
    Front Pharmacol15, 1421598-1421598. PubMed  Europe PubMed DOI
  14. Fahndrich,S. and Bals,R.
    [Alpha 1-antitrypsin deficiency]
    Inn Med (Heidelb)65, 533-537. PubMed  Europe PubMed DOI
  15. Kontoh-Twumasi,R., Budkin,S., Edupuganti,N., Vashishtha,A. and Sharma,S.
    Role of Serine Protease Inhibitors A1 and A3 in Ocular Pathologies
    Invest Ophthalmol Vis Sci65, 16-16. PubMed  Europe PubMed DOI  V
  16. Lietz,S., Sokolowski,L.M., Barth,H. and Ernst,K.
    Alpha-1 antitrypsin inhibits Clostridium botulinum C2 toxin, Corynebacterium diphtheriae diphtheria toxin and B. anthracis fusion toxin
    Sci Rep14, 21257-21257. PubMed  Europe PubMed DOI
  17. Martinelli,I., Zucchi,E., Simonini,C., Gianferrari,G., Bedin,R., Biral,C., Ghezzi,A., Fini,N., Carra,S. and Mandrioli,J.
    SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study
    Eur J Neurol31, e16054-e16054. PubMed  Europe PubMed DOI
  18. Mohammad,N., Oshins,R., Gu,T., Clark,V., Lascano,J., Assarzadegan,N., Marek,G., Brantly,M. and Khodayari,N.
    Liver Characterization of a Cohort of Alpha-1 Antitrypsin Deficiency Patients with and without Lung Disease
    J Clin Transl Hepatol12, 845-856. PubMed  Europe PubMed DOI
  19. Mulkareddy,V. and Roman,J.
    Pulmonary manifestations of alpha 1 antitrypsin deficiency
    Am J Med Sci368, 1-8. PubMed  Europe PubMed DOI  V
  20. Okagawa,S., Sakaguchi,M., Okubo,Y., Takekuma,Y., Igata,M., Kondo,T., Takeda,N., Araki,K., Brandao,B.B., Qian,W.J., Tseng,Y.H., Kulkarni,R.N., Kubota,N., Kahn,C.R. and Araki,E.
    Hepatic SerpinA1 improves energy and glucose metabolism through regulation of preadipocyte proliferation and UCP1 expression
    Nat Commun15, 9585-9585. PubMed  Europe PubMed DOI
  21. Xiubing,C., Huazhen,L., Xueyan,W., Jing,N., Qing,L., Haixing,J., Shanyu,Q. and Jiefu,L.
    SERPINA1 promotes the invasion, metastasis, and proliferation of pancreatic ductal adenocarcinoma via the PI3K/Akt/NF-kappaB pathway
    Biochem Pharmacol230, 116580-116580. PubMed  Europe PubMed DOI  K
  22. 2023
  23. Bai,X., Schountz,T., Buckle,A.M., Talbert,J.L., Sandhaus,R.A. and Chan,E.D.
    Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence
    Biochem Soc Trans51, 1361-1375. PubMed  Europe PubMed DOI
  24. Kaur,U., Kihn,K.C., Ke,H., Kuo,W., Gierasch,L.M., Hebert,D.N., Wintrode,P.L., Deredge,D. and Gershenson,A.
    The conformational landscape of a serpin N-terminal subdomain facilitates folding and in-cell quality control
    bioRxiv PubMed  Europe PubMed DOI
  25. Khoshdel,A., Forootan,M., Afsharinasab,M., Rezaian,M. and Abbasifard,M.
    Assessment of the circulatory concentrations of cathepsin D, cathepsin K, and alpha-1 antitrypsin in patients with knee osteoarthritis
    Ir J Med Sci192, 1191-1196. PubMed  Europe PubMed DOI
  26. Wiesemann,G.S., Oshins,R.A., Flagg,T.O. and Brantly,M.L.
    Novel SERPINA1 Alleles Identified through a Large Alpha-1 Antitrypsin Deficiency Screening Program and Review of Known Variants
    Chronic Obstr Pulm Dis10, 7-21. PubMed  Europe PubMed DOI  V
  27. Wu,T., Hagiwara,M., Gnass,E., Barman,H., Sasson,D., Treem,W., Ren,K., Marins,E.G., Karki,C. and Malhi,H.
    Liver disease progression in patients with alpha-1 antitrypsin deficiency and protease inhibitor ZZ genotype with or without lung disease
    Aliment Pharmacol Ther58, 1075-1085. PubMed  Europe PubMed DOI
  28. 2022
  29. Akbasheva,O.E., Spirina,L.V., Dyakov,D.A. and Masunova,N.V.
    [Proteolysis and deficiency of alpha1-proteinase inhibitor in SARS-CoV-2 infection]
    Biomed Khim68, 157-176. PubMed  Europe PubMed DOI  V
  30. Akbasheva,O.E., Spirina,L.V., Dyakov,D.A. and Masunova,N.V.
    Proteolysis and Deficiency of alpha1-Proteinase Inhibitor in SARS-CoV-2 Infection
    Biochem Mosc Suppl B Biomed Chem16, 271-291. PubMed  Europe PubMed DOI  V
  31. D'Amato,M., Vertui,V., Pandolfi,L., Bozzini,S., Fossali,T., Colombo,R., Aliberti,A., Fumagalli,M., Iadarola,P., Dido,C., Viglio,S. and Meloni,F.
    Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients
    Curr Issues Mol Biol44, 2122-2138. PubMed  Europe PubMed DOI
  32. Grayeski,P.J., Weidmann,C.A., Kumar,J., Lackey,L., Mustoe,A.M., Busan,S., Laederach,A. and Weeks,K.M.
    Global 5'-UTR RNA structure regulates translation of a SERPINA1 mRNA
    Nucleic Acids Res50, 9689-9704. PubMed  Europe PubMed DOI
  33. Liu,W., Du,M., Wan,H., Yang,H., Deng,X., Chen,Y. and Zhang,Q.
    Serpin family A member 1 is an oncogene in glioma and its translation is enhanced by NAD(P)H quinone dehydrogenase 1 through RNA-binding activity
    Open Med (Wars)17, 1645-1654. PubMed  Europe PubMed DOI
  34. Liu,X., Kouassi,K.G.W., Vanbever,R. and Dumoulin,M.
    Impact of the PEG length and PEGylation site on the structural, thermodynamic, thermal, and proteolytic stability of mono-PEGylated alpha-1 antitrypsin
    Protein Sci31, e4392-e4392. PubMed  Europe PubMed DOI
  35. Miravitlles,M., Turner,A.M., Torres-Duran,M., Tanash,H., Rodriguez-Garcia,C., Lopez-Campos,J.L., Chlumsky,J., Guimaraes,C., Rodriguez-Hermosa,J.L., Corsico,A., Martinez-Gonzalez,C., Hernandez-Perez,J.M., Bustamante,A., Parr,D.G., Casas-Maldonado,F., Hecimovic,A., Janssens,W., Lara,B., Barrecheguren,M., Gonzalez,C., Stolk,J., Esquinas,C. and Clarenbach,C.F.
    Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
    Respir Res23, 352-352. PubMed  Europe PubMed DOI
  36. O'Brien,M.E., Murray,G., Gogoi,D., Yusuf,A., McCarthy,C., Wormald,M.R., Casey,M., Gabillard-Lefort,C., McElvaney,N.G. and Reeves,E.P.
    A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application
    Int J Mol Sci23, PubMed  Europe PubMed DOI  V
  37. Pini,L., Giordani,J., Ciarfaglia,M., Pini,A., Arici,M. and Tantucci,C.
    Alpha1-antitrypsin deficiency and cardiovascular disease: questions and issues of a debated relation
    J Cardiovasc Med (Hagerstown)23, 637-645. PubMed  Europe PubMed DOI  V
  38. Strnad,P., Mandorfer,M., Choudhury,G., Griffiths,W., Trautwein,C., Loomba,R., Schluep,T., Chang,T., Yi,M., Given,B.D., Hamilton,J.C., San Martin,J. and Teckman,J.H.
    Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency
    N Engl J Med387, 514-524. PubMed  Europe PubMed DOI
  39. Sun,R., Xu,Z., Zhu,C., Chen,T., Munoz,L.E., Dai,L. and Zhao,Y.
    Alpha-1 antitrypsin in autoimmune diseases: Roles and therapeutic prospects
    Int Immunopharmacol110, 109001-109001. PubMed  Europe PubMed DOI  V
  40. Tiensuu,H., Haapalainen,A.M., Tissarinen,P., Pasanen,A., Maatta,T.A., Huusko,J.M., Ohlmeier,S., Bergmann,U., Ojaniemi,M., Muglia,L.J., Hallman,M. and Ramet,M.
    Human placental proteomics and exon variant studies link AAT/SERPINA1 with spontaneous preterm birth
    BMC Med20, 141-141. PubMed  Europe PubMed DOI  K
  41. Wilkinson,D.J., Falconer,A.M.D., Wright,H.L., Lin,H., Yamamoto,K., Cheung,K., Charlton,S.H., Arques,M.D.C., Janciauskiene,S., Refaie,R., Rankin,K.S., Young,D.A. and Rowan,A.D.
    Matrix metalloproteinase-13 is fully activated by neutrophil elastase and inactivates its serpin inhibitor, alpha-1 antitrypsin: Implications for osteoarthritis
    FEBS J289, 121-139. PubMed  Europe PubMed
  42. Zhang,L.Y., Sun,X.W., Ding,Y.J., Yan,Y.R., Wang,Y., Li,C.X., Li,S.Q., Zhang,L., Song,H.J., Li,H.P. and Li,Q.Y.
    SERPINA1 Methylation Levels are Associated with Lung Cancer Development in Male Patients with Chronic Obstructive Pulmonary Disease
    Int J Chron Obstruct Pulmon Dis17, 2117-2125. PubMed  Europe PubMed DOI
  43. Zhang,Y., Zhu,M., Zheng,C., Wei,W., Emmer,B.T. and Zhang,B.
    LMAN1-MCFD2 complex is a cargo receptor for the ER-Golgi transport of alpha1-antitrypsin
    Biochem J479, 839-855. PubMed  Europe PubMed DOI
  44. Zieger,M., Borel,F., Greer,C., Gernoux,G., Blackwood,M., Flotte,T.R. and Mueller,C.
    Liver-directed SERPINA1 gene therapy attenuates progression of spontaneous and tobacco smoke-induced emphysema in alpha1-antitrypsin null mice
    Mol Ther Methods Clin Dev25, 425-438. PubMed  Europe PubMed DOI
  45. 2021
  46. Aiello,M., Ghirardini,M., Marchi,L., Frizzelli,A., Pisi,R., Ferrarotti,I., Bertorelli,G. and Chetta,A.
    Air Trapping Is Associated with Heterozygosity for Alpha-1 Antitrypsin Mutations in Patients with Asthma
    Respiration1-10. PubMed  Europe PubMed DOI
  47. Ando,Y., Kuroda,A., Kusama,K., Matsutani,T., Matsuda,A. and Tamura,K.
    Impact of serine protease inhibitor alpha1-antitrypsin on expression of endoplasmic reticulum stress-induced proinflammatory factors in adipocytes
    Biochem Biophys Rep26, 100967-100967. PubMed  Europe PubMed DOI
  48. Azouz,N.P., Klingler,A.M., Callahan,V., Akhrymuk,I.V., Elez,K., Raich,L., Henry,B.M., Benoit,J.L., Benoit,S.W., Noe,F., Kehn-Hall,K. and Rothenberg,M.E.
    Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2
    Pathog Immun6, 55-74. PubMed  Europe PubMed DOI
  49. Bhakta,V., Hamada,M., Nouanesengsy,A., Lapierre,J., Perruzza,D.L. and Sheffield,W.P.
    Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis
    Sci Rep11, 5565-5565. PubMed  Europe PubMed DOI
  50. Bhattacharyya,C., Das,C., Ghosh,A., Singh,A.K., Mukherjee,S., Majumder,P.P., Basu,A. and Biswas,N.K.
    SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions
    Infect Genet Evol90, 104760-104760. PubMed  Europe PubMed DOI
  51. Bianchera,A., Alomari,E. and Bruno,S.
    Augmentation therapy with alpha 1-antitrypsin: present and future of production, formulation, and delivery
    Curr Med Chem PubMed  Europe PubMed DOI  V
  52. Campbell,R.A., Campbell,H.D., Bircher,J.S., de Araujo,C.V., Denorme,F., Crandell,J.L., Rustad,J.L., Monts,J., Cody,M.J., Kosaka,Y. and Yost,C.C.
    Placental HTRA1 cleaves alpha-1-antitrypsin to generate a NET-Inhibitory Peptide
    Blood PubMed  Europe PubMed DOI
  53. Engelmaier,A. and Weber,A.
    Sensitive and specific measurement of alpha1-antitrypsin activity with an elastase complex formation immunosorbent assay (ECFISA)
    J Pharm Biomed Anal114476-114476. PubMed  Europe PubMed DOI
  54. Fazleen,A. and Wilkinson,T.
    The emerging role of proteases in alpha1-antitrypsin deficiency and beyond
    ERJ Open Res7, PubMed  Europe PubMed DOI
  55. Ferrarotti,I., Ottaviani,S., Balderacchi,A.M., Barzon,V., De Silvestri,A., Piloni,D., Mariani,F. and Corsico,A.G.
    COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale
    Respir Med183, 106440-106440. PubMed  Europe PubMed DOI
  56. Hakim,A., Moll,M., Qiao,D., Liu,J., Lasky-Su,J.A., Silverman,E.K., Vilarinho,S., Jiang,Z.G., Hobbs,B.D. and Cho,M.H.
    Heterozygosity of the Alpha 1-Antitrypsin Pi*Z Allele and Risk of Liver Disease
    Hepatol Commun5, 1348-1361. PubMed  Europe PubMed DOI
  57. Hamada,M., Bhakta,V., Andres,S.N. and Sheffield,W.P.
    Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant
    Front Cardiovasc Med8, 647405-647405. PubMed  Europe PubMed DOI
  58. Hawkins,P., Sya,J., Hup,N.K., Murphy,M.P., McElvaney,N.G. and Reeves,E.P.
    Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals
    Medicina (Kaunas)57, PubMed  Europe PubMed DOI
  59. Hogan,G., Geoghegan,P., Carroll,T.P., Clarke,J., McElvaney,O.F., McElvaney,O.J., McElvaney,N.G. and Curley,G.F.
    alpha1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome?
    Anesthesiology134, 792-808. PubMed  Europe PubMed DOI
  60. Leon,C. and Bouchecareilh,M.
    The Autophagy Pathway: A Critical Route in the Disposal of Alpha 1-Antitrypsin Aggregates That Holds Many Mysteries
    Int J Mol Sci22, PubMed  Europe PubMed DOI  V
  61. Martinez-Gonzalez,C., Blanco,I., Diego,I., Bueno,P. and Miravitlles,M.
    Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide
    Int J Chron Obstruct Pulmon Dis16, 2617-2630. PubMed  Europe PubMed DOI  V
  62. Meza-Segura,M., Birtley,J.R., Maldonado-Contreras,A., Mueller,C., Simin,K.J., Stern,L.J. and McCormick,B.A.
    SepA Enhances Shigella Invasion of Epithelial Cells by Degrading Alpha-1 Antitrypsin and Producing a Neutrophil Chemoattractant
    MBioe0283321-e0283321. PubMed  Europe PubMed DOI
  63. Ostermann,L., Maus,R., Stolper,J., Schutte,L., Katsarou,K., Tumpara,S., Pich,A., Mueller,C., Janciauskiene,S., Welte,T. and Maus,U.A.
    Alpha-1 antitrypsin deficiency impairs lung antibacterial immunity in mice
    JCI Insight6, PubMed  Europe PubMed DOI
  64. Pini,L., Tiberio,L., Arici,M., Corda,L., Giordani,J., Bargagli,E. and Tantucci,C.
    Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in alfa-1 anti-trypsin deficiency-related COPD development?
    Monaldi Arch Chest Dis PubMed  Europe PubMed DOI
  65. Pini,L., Paoletti,G., Heffler,E., Tantucci,C., Puggioni,F., Corsico,A., Del Giacco,S., Ferri,S., Giordani,J., Paggiaro,P., Pini,A. and Spanevello,A.
    Alpha1-antitrypsin deficiency and asthma
    Curr Opin Allergy Clin Immunol21, 46-51. PubMed  Europe PubMed DOI  V
  66. Seixas,S. and Marques,P.I.
    Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum
    Appl Clin Genet14, 173-194. PubMed  Europe PubMed DOI
  67. Stearns,K., Goldklang,M., Xiao,R., Zelonina,T., Blomenkamp,K., Teckman,J. and D'Armiento,J.M.
    Knockdown of Alpha-1 Antitrypsin with antisense oligonucleotide does not exacerbate smoke induced lung injury
    PLoS ONE16, e0246040-e0246040. PubMed  Europe PubMed DOI  K
  68. Tumpara,S., Korenbaum,E., Kuhnel,M., Jonigk,D., Olejnicka,B., Davids,M., Welte,T., Martinez-Delgado,B. and Janciauskiene,S.
    A Novel Mouse Monoclonal Antibody C42 against C-Terminal Peptide of Alpha-1-Antitrypsin
    Int J Mol Sci22, PubMed  Europe PubMed DOI
  69. Wettstein,L., Weil,T., Conzelmann,C., Muller,J.A., Gross,R., Hirschenberger,M., Seidel,A., Klute,S., Zech,F., Prelli Bozzo,C., Preising,N., Fois,G., Lochbaum,R., Knaff,P.M., Mailander,V., Standker,L., Thal,D.R., Schumann,C., Stenger,S., Kleger,A., Lochnit,G., Mayer,B., Ruiz-Blanco,Y.B., Hoffmann,M., Sparrer,K.M.J., Pohlmann,S., Sanchez-Garcia,E., Kirchhoff,F., Frick,M. and Munch,J.
    Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
    Nat Commun12, 1726-1726. PubMed  Europe PubMed DOI
  70. 2020
  71. Attanasio,S., Ferriero,R., Gernoux,G., De Cegli,R., Carissimo,A., Nusco,E., Campione,S., Teckman,J., Mueller,C., Piccolo,P. and Brunetti-Pierri,N.
    CHOP and c-JUN upregulate the mutant Z alpha-1 antitrypsin, exacerbating its aggregation and liver proteotoxicity
    J Biol Chem PubMed  Europe PubMed DOI
  72. Aymonnier,K., Kawecki,C., Arocas,V., Boulaftali,Y. and Bouton,M.C.
    Serpins, New Therapeutic Targets for Hemophilia
    Thromb Haemost PubMed  Europe PubMed DOI  V
  73. Azouz,N.P., Klingler,A.M., Callahan,V., Akhrymuk,I.V., Elez,K., Raich,L., Henry,B.M., Benoit,J.L., Benoit,S.W., Noe,F., Kehn-Hall,K. and Rothenberg,M.E.
    Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2
    bioRxiv PubMed  Europe PubMed DOI
  74. Belchamber,K.B.R., Walker,E.M., Stockley,R.A. and Sapey,E.
    Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
    Int J Chron Obstruct Pulmon Dis15, 3183-3192. PubMed  Europe PubMed DOI  V
  75. Bidla,G., Rosenblatt,D.S. and Gilfix,B.M.
    Identification of Variants in Alpha-1-Antitrypsin by High Resolution Melting
    J Appl Lab Med PubMed  Europe PubMed DOI
  76. Blanco,I., Diego,I., Bueno,P., Perez-Holanda,S., Casas-Maldonado,F. and Miravitlles,M.
    Prevalence of alpha1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review
    Eur Respir Rev29, PubMed  Europe PubMed DOI
  77. Bojkova,D., Bechtel,M., McLaughlin,K.M., McGreig,J.E., Klann,K., Bellinghausen,C., Rohde,G., Jonigk,D., Braubach,P., Ciesek,S., Munch,C., Wass,M.N., Michaelis,M. and Cinatl,J., Jr.
    Aprotinin Inhibits SARS-CoV-2 Replication
    Cells9, PubMed  Europe PubMed DOI
  78. Chuang,H.C., Chen,Y.Y., Hsiao,T.C., Chou,H.C., Kuo,H.P., Feng,P.H., Ho,S.C., Chen,J.K., Chuang,K.J. and Lee,K.Y.
    Alteration in angiotensin-converting enzyme 2 by PM1 during the development of emphysema in rats
    ERJ Open Res6, PubMed  Europe PubMed DOI
  79. Ferrari da Cruz,T., Rufino,R., Lopes,A.J., Noronha,A., Medeiros Anselmo,F. and Henrique da Costa,C.
    Evaluation of the Small Airways in Patients with Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency
    Int J Chron Obstruct Pulmon Dis15, 2267-2274. PubMed  Europe PubMed DOI
  80. Jagger,A.M., Waudby,C.A., Irving,J.A., Christodoulou,J. and Lomas,D.A.
    High-resolution ex vivo NMR spectroscopy of human Z alpha1-antitrypsin
    Nat Commun11, 6371-6371. PubMed  Europe PubMed DOI
  81. Lechowicz,U., Rudzinski,S., Jezela-Stanek,A., Janciauskiene,S. and Chorostowska-Wynimko,J.
    Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein
    Int J Mol Sci21, PubMed  Europe PubMed DOI  V
  82. Lior,Y., Jasevitch,M., Ochayon,D.E., Zaretsky,M., Lewis,E.C. and Aharoni,A.
    Application of directed evolution and back-to-consensus algorithms to human alpha1-antitrypsin leads to diminished anti-protease activity and augmented anti-inflammatory activities
    Cell Immunol355, 104135-104135. PubMed  Europe PubMed DOI
  83. Lopez-Campos,J.L., Carrasco Hernandez,L. and Caballero Eraso,C.
    Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy
    J Clin Med9, PubMed  Europe PubMed DOI  V
  84. McNulty,M.J., Silberstein,D.Z., Kuhn,B.T., Padgett,H.S., Nandi,S., McDonald,K.A. and Cross,C.E.
    Alpha-1 antitrypsin deficiency and recombinant protein sources with focus on plant sources: Updates, challenges and perspectives
    Free Radic Biol Med163, 10-30. PubMed  Europe PubMed DOI  V
  85. Park,J.E., Tran,T.X.T., Park,N., Yeom,J., Kim,K. and Kang,M.J.
    The Function of Drosophila USP14 in Endoplasmic Reticulum Stress and Retinal Degeneration in a Model for Autosomal Dominant Retinitis Pigmentosa
    Biology (Basel)9, PubMed  Europe PubMed DOI
  86. Perez-Rubio,G., Ambrocio-Ortiz,E., Lopez-Flores,L.A., Juarez-Martin,A.I., Jimenez-Valverde,L.O., Zoreque-Cabrera,S., Galicia-Negrete,G., Ramirez-Diaz,M.E., Cruz-Vicente,F., Castillejos-Lopez,M.J., Salinas-Lara,C., Hernandez-Zenteno,R.J., Ramirez-Venegas,A. and Falfan-Valencia,R.
    Heterozygous Genotype rs17580 AT (PiS) in SERPINA1 is Associated with COPD Secondary to Biomass-Burning and Tobacco Smoking: A Case-Control and Populational Study
    Int J Chron Obstruct Pulmon Dis15, 1181-1190. PubMed  Europe PubMed DOI
  87. Rottier,S.J., Dreuning,L.C., van Pelt,J., van Geloven,A.A.W., Beele,X.D.Y., Huisman,P.M., Deurholt,W.Y., Rottier,C.A., van Leeuwen,K., de Boer,M., van Mierlo,G., Boermeester,M.A.A. and Schreurs,W.H.
    Alpha-1-Antitrypsin deficiency (carrier) as possible risk factor for development of colonic diverticula. A multicentre prospective case-control study: The ALADDIN study
    Colorectal Dis PubMed  Europe PubMed DOI
  88. Scott,B.M. and Sheffield,W.P.
    Engineering the serpin alpha1-antitrypsin: a diversity of goals and techniques
    Protein Sci29, 856-871. PubMed  Europe PubMed DOI
  89. Scott,B.M., Matochko,W.L., Gierczak,R.F., Bhakta,V., Derda,R. and Sheffield,W.P.
    Correction: Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin
    PLoS ONE15, e0238969-e0238969. PubMed  Europe PubMed DOI
  90. Shapira,G., Shomron,N. and Gurwitz,D.
    Ethnic differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID-19 fatality rates
    FASEB J34, 14160-14165. PubMed  Europe PubMed DOI
  91. Sosulski,M.L., Stiles,K.M., Frenk,E.Z., Hart,F.M., Matsumura,Y., De,B.P., Kaminsky,S.M. and Crystal,R.G.
    Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
    JCI Insight5, PubMed  Europe PubMed DOI
  92. Stockley,R.A.
    Alpha-1 antitrypsin deficiency: have we got the right proteinase?
    Chronic Obstr Pulm Dis7, PubMed  Europe PubMed DOI
  93. Tumpara,S., Martinez-Delgado,B., Gomez-Mariano,G., Liu,B., DeLuca,D.S., Korenbaum,E., Jonigk,D., Jugert,F., Wurm,F.M., Wurm,M.J., Welte,T. and Janciauskiene,S.
    The Delivery of alpha1-Antitrypsin Therapy Through Transepidermal Route: Worthwhile to Explore
    Front Pharmacol11, 983-983. PubMed  Europe PubMed DOI
  94. Yang,C., Keshavjee,S. and Liu,M.
    Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation
    Front Pharmacol11, 615398-615398. PubMed  Europe PubMed DOI
  95. 2019
  96. Campos,M.A., Geraghty,P., Holt,G., Mendes,E., Newby,P.R., Ma,S., Luna-Diaz,L.V., Turino,G.M. and Stockley,R.A.
    The biological effects of double-dose alpha-1 antitrypsin augmentation therapy. A pilot clinical trial
    Am J Respir Crit Care Med200, 318-326. PubMed  Europe PubMed DOI  U
  97. Zhang,N., Wright,T., Caraway,P. and Xu,J.
    Enhanced secretion of human alpha1-antitrypsin expressed with a novel glycosylation module in tobacco BY-2 cell culture
    Bioengineered10, 87-97. PubMed  Europe PubMed DOI  E
  98. 2018
  99. Chapman,K.R., Chorostowska-Wynimko,J., Koczulla,A.R., Ferrarotti,I. and McElvaney,N.G.
    Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
    Int J Chron Obstruct Pulmon Dis13, 419-432. PubMed  Europe PubMed DOI  U
  100. Giri Rao,V.V.H. and Gosavi,S.
    On the folding of a structurally complex protein to its metastable active state
    Proc Natl Acad Sci U S A115, 1998-2003. PubMed  Europe PubMed DOI  S
  101. Julicher,K., Wahner,A., Haase,K., Barbour,K.W., Berger,F.G., Wiehlmann,L., Davenport,C., Schuster-Gossler,K., Stitz,J., Cantz,T. and Eggenschwiler,R.
    Functional characterization of the mouse Serpina1 paralog DOM-7
    Biol Chem399, 577-582. PubMed  Europe PubMed DOI
  102. Lior,Y., Zaretsky,M., Ochayon,D.E., Lotysh,D., Baranovski,B.M., Schuster,R., Guttman,O., Aharoni,A. and Lewis,E.C.
    Point mutation of a non-elastase-binding site in human alpha1-antitrypsin alters its anti-inflammatory properties
    Front Immunol9, 759-759. PubMed  Europe PubMed DOI
  103. Morifuji,Y., Xu,J., Karasaki,N., Iiyama,K., Morokuma,D., Hino,M., Masuda,A., Yano,T., Mon,H., Kusakabe,T. and Lee,J.M.
    Expression, purification, and characterization of recombinant human alpha1-antitrypsin produced using silkworm-baculovirus expression system
    Mol Biotechnol60, 924-934. PubMed  Europe PubMed DOI  E
  104. 2017
  105. Andersen,O.J., Risor,M.W., Poulsen,E.C., Nielsen,N.C., Miao,Y., Enghild,J.J. and Schiott,B.
    Reactive center loop insertion in alpha-1-antitrypsin captured by accelerated molecular dynamics simulation
    Biochemistry56, 634-646. PubMed  Europe PubMed DOI  S
  106. Boerema,D.J., An,B., Gandhi,R.P., Papineau,R., Regnier,E., Wilder,A., Molitor,A., Tang,A.P. and Kee,S.M.
    Biochemical comparison of four commercially available human alpha1-proteinase inhibitors for treatment of alpha1-antitrypsin deficiency
    Biologicals50, 63-72. PubMed  Europe PubMed DOI  U
  107. Carpagnano,G.E., Santacroce,R., Palmiotti,G.A., Leccese,A., Giuffreda,E., Margaglione,M., Foschino Barbaro,M.P., Aliberti,S. and Lacedonia,D.
    A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis
    Lung195, 679-682. PubMed  Europe PubMed DOI  M
  108. Chung,H.S., Kim,J.S., Lee,S.M. and Park,S.J.
    Role of the P2 residue of human alpha 1-antitrypsin in determining target protease specificity
    PLoS ONE12, e0185074-e0185074. PubMed  Europe PubMed DOI
  109. Crystal,R.G.
    Compelling evidence for the efficacy of alpha1-antitrypsin augmentation treatment for alpha1-antitrypsin deficiency
    Lancet Respir Med5, 7-8. PubMed  Europe PubMed DOI  U
  110. Huangfu,C., Zhang,J., Ma,Y., Jia,J., Lv,M., Zhao,X. and Zhang,J.
    New process for purifying high purity alpha1-antitrypsin from Cohn Fraction IV by chromatography: a promising method for the better utilization of plasma
    J Chromatogr B Analyt Technol Biomed Life Sci1046, 156-164. PubMed  Europe PubMed DOI  U
  111. Kee,S., Weber,D., Popp,B., Nowak,T., Schafer,W., Groner,A. and Roth,N.J.
    Pathogen safety and characterisation of a highly purified human alpha1-proteinase inhibitor preparation
    Biologicals47, 25-32. PubMed  Europe PubMed DOI  U
  112. Li,W., Wang,Q., Li,S., Jiang,A. and Sun,W.
    Molecular cloning, genomic structure, polymorphism analysis and recombinant expression of a alpha1-antitrypsin like gene from swamp eel, Monopterus albus
    Fish Shellfish Immunol62, 124-138. PubMed  Europe PubMed DOI
  113. McElvaney,N.G., Burdon,J., Holmes,M., Glanville,A., Wark,P.A., Thompson,P.J., Hernandez,P., Chlumsky,J., Teschler,H., Ficker,J.H., Seersholm,N., Altraja,A., Makitaro,R., Chorostowska-Wynimko,J., Sanak,M., Stoicescu,P.I., Piitulainen,E., Vit,O., Wencker,M., Tortorici,M.A., Fries,M., Edelman,J.M. and Chapman,K.R.
    Long-term efficacy and safety of alpha1 proteinase inhibitor treatment for emphysema caused by severe alpha1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
    Lancet Respir Med5, 51-60. PubMed  Europe PubMed DOI  U
  114. Parr,D.G. and Lara,B.
    Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature
    Drug Des Devel Ther11, 2149-2162. PubMed  Europe PubMed DOI  U
  115. 2016
  116. Akbas,N., Gonzalez,G., Buffone,G.J., Grenache,D.G. and Devaraj,S.
    A library of rare alpha1-antitrypsin (AAT) variant phenotypes to aid in the diagnosis of AAT deficiency
    Am J Clin Pathol146, 289-293. PubMed  Europe PubMed DOI  M
  117. Gogol,M., Ostrowska,D., Klaga,K., Bochenska,O., Wolak,N., Aoki,W., Ueda,M., Kozik,A. and Rapala-Kozik,M.
    Inactivation of alpha1-proteinase inhibitor by Candida albicans aspartic proteases favors the epithelial and endothelial cell colonization in the presence of neutrophil extracellular traps
    Acta Biochim Pol63, 167-175. PubMed  Europe PubMed DOI
  118. Huang,X., Zheng,Y., Zhang,F., Wei,Z., Wang,Y., Carrell,R.W., Read,R.J., Chen,G.-Q. and Zhou,A.
    Molecular mechanism of Z alpha1-antitrypsin deficiency
    J Biol Chem291, 15674-15686. PubMed  Europe PubMed DOI  M
  119. Jha,S., Agarwal,S., Sanyal,I. and Amla,D.V.
    Single-step purification and characterization of a recombinant serine proteinase inhibitor from transgenic plants
    Appl Biochem Biotechnol179, 220-236. PubMed  Europe PubMed DOI  E  U
  120. Lomas,D.A., Hurst,J.R. and Gooptu,B.
    Update on alpha-1 antitrypsin deficiency: new therapies
    J Hepatol65, 413-424. PubMed  Europe PubMed DOI  M
  121. Motamedi-Shad,N., Jagger,A.M., Liedtke,M., Faull,S.V., Nanda,A.S., Salvadori,E., Wort,J.L., Kay,C.W.M., Heyer-Chauhan,N., Miranda,E., Perez,J., Ordonez,A., Haq,I., Irving,J.A. and Lomas,D.A.
    An antibody that prevents serpin polymerisation acts by inducing a novel allosteric behavior
    Biochem J473, 3269-3290. PubMed  Europe PubMed DOI
  122. Perlmutter,D.H.
    alpha1-Antitrypsin deficiency: a misfolded secretory protein variant with unique effects on the endoplasmic reticulum
    Endoplasmic Reticulum Stress Dis3, 63-72. PubMed  Europe PubMed DOI  M
  123. Sheffield,W.P. and Bhakta,V.
    The M358R variant of alpha(1)-proteinase inhibitor inhibits coagulation factor VIIa
    Biochem Biophys Res Commun470, 710-713. PubMed  Europe PubMed DOI  M
  124. Zhou,X. and Declerck,P.J.
    Prevention of serpin misfolding by RNA aptamers
    Cell Chem Biol23, 639-640. PubMed  Europe PubMed DOI  I
  125. 2015
  126. Berthelier,V., Harris,J.B., Estenson,K.N. and Baudry,J.
    Discovery of an inhibitor of Z-alpha1 antitrypsin polymerization
    PLoS ONE10, 0126256- PubMed  Europe PubMed DOI
  127. Gierczak,R.F., Bhakta,V., Xie,M. and Sheffield,W.P.
    Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity
    J Biotechnol208, 54-62. PubMed  Europe PubMed DOI  M
  128. Parambeth,J.C., Suchodolski,J.S. and Steiner,J.M.
    Purification and partial characterization of alpha1-proteinase inhibitor in the common marmoset (Callithrix jacchus)
    Res Vet Sci99, 17-22. PubMed  Europe PubMed DOI
  129. Rahman,M.A., Mitra,S., Sarkar,A. and Wewers,M.D.
    Alpha 1-antitrypsin does not inhibit human monocyte caspase-1
    PLoS ONE10, e0117330-e0117330. PubMed  Europe PubMed DOI
  130. Shi,C., Zhang,G., Han,B., Yang,J., Liu,H. and Xi,J.
    [Effects of alpha1-PDX, a furin inhibitor, on growth, invasion, and tumorigenicity of cervical cancer HeLa cells]
    Nan Fang Yi Ke Da Xue Xue Bao35, 432-436. PubMed  Europe PubMed
  131. 2014
  132. Behrens,M.A., Sendall,T.J., Pedersen,J.S., Kjeldgaard,M., Huntington,J.A. and Jensen,J.K.
    The shapes of Z-alpha1-antitrypsin polymers in solution support the C-terminal domain-swap mechanism of polymerization
    Biophys J107, 1905-1912. PubMed  Europe PubMed DOI  M  S
  133. Chiuchiolo,M.J., Kaminsky,S.M., Sondhi,D., Mancenido,D., Hollmann,C. and Crystal,R.G.
    Phase I/II study of intrapleural administration of a serotype rh.10 replication-deficient adeno-associated virus gene transfer vector expressing the human alpha1-antitrypsin cDNA to individuals with alpha1-antitrypsin deficiency
    Hum Gene Ther Clin Develop25, 112-133. PubMed  Europe PubMed DOI  U
  134. Ferrarotti,I., Carroll,T.P., Ottaviani,S., Fra,A.M., O Brien,G., Molloy,K., Corda,L., Medicina,D., Curran,D.R., McElvaney,N.G. and Luisetti,M.
    Identification and characterisation of eight novel SERPINA1 null mutations
    Orphanet J Rare Dis9, 172-172. PubMed  Europe PubMed DOI  M
  135. Frochaux,V., Hildebrand,D., Talke,A., Linscheid,M.W. and Schluter,H.
    Alpha-1-antitrypsin: a novel human high temperature requirement protease A1 (HTRA1) substrate in human placental tissue
    PLoS ONE9, e109483-e109483. PubMed  Europe PubMed DOI
  136. Ghouse,R., Chu,A., Wang,Y. and Perlmutter,D.H.
    Mysteries of alpha1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease
    Dis Model Mech7, 411-419. PubMed  Europe PubMed DOI  M  V
  137. Gierczak,R.F., Pepler,L., Bhagirath,V., Liaw,P.C. and Sheffield,W.P.
    Alpha-1 proteinase inhibitor M358R reduces thrombin generation when displayed on the surface of cells expressing tissue factor
    Thromb Res134, 1142-1149. PubMed  Europe PubMed DOI  U
  138. Gooptu,B., Dickens,J.A. and Lomas,D.A.
    The molecular and cellular pathology of alpha1-antitrypsin deficiency
    Trends Mol Med20, 116-127. PubMed  Europe PubMed DOI  M
  139. Jha,S., Sanyal,I. and Amla,D.V.
    Single amino acid substitutions in recombinant plant-derived human alpha1-proteinase inhibitor confer enhanced stability and functional efficacy
    Biochim Biophys Acta1840, 416-427. PubMed  Europe PubMed DOI  E  U
  140. Joly,P., Lacan,P., Chapuis-Cellier,C., Garcia,C., Bererd,M. and Francina,A.
    Molecular characterization of 7 new alpha-1 anti-trypsin (A1AT) variants including two with an associated deficient phenotype
    Clin Chim Acta427, 21-22. PubMed  Europe PubMed DOI  M
  141. Lara,B., Martinez,M.T., Blanco,I., Hernandez-Moro,C., Velasco,E.A., Ferrarotti,I., Rodriguez-Frias,F., Perez,L., Vazquez,I., Alonso,J., Posada,M. and Martinez-Delgado,B.
    Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid
    Respir Res15, 125-125. PubMed  Europe PubMed DOI  M
  142. Liu,L., Werner,M. and Gershenson,A.
    Collapse of a long axis: single-molecule Forster resonance energy transfer and serpin equilibrium unfolding
    Biochemistry53, 2903-2914. PubMed  Europe PubMed DOI
  143. Ljujic,M., Divac Rankov,A., Kojic,S., Miranda,E. and Radojkovic,D.
    Functional analysis of novel alpha-1 antitrypsin variants G320R and V321F
    Mol Biol Rep41, 6133-6141. PubMed  Europe PubMed DOI  M
  144. Sinden,N.J., Koura,F. and Stockley,R.A.
    The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote
    BMC Pulm Med14, 132-132. PubMed  Europe PubMed DOI  M
  145. Yang,L., Dinarvand,P., Qureshi,S.H. and Rezaie,A.R.
    Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin
    Thromb Haemost112, 164-175. PubMed  Europe PubMed DOI  E
  146. 2013
  147. Hada,K., Isshiki,K., Matsuda,S., Yuasa,K. and Tsuji,A.
    Engineering of alpha1-antitrypsin variants with improved specificity for the proprotein convertase furin using site-directed random mutagenesis
    Protein Eng Des Sel26, 123-131. PubMed  Europe PubMed DOI
  148. Haq,I., Irving,J.A., Faull,S.V., Dickens,J.A., Ordnez,A., Belorgey,D., Gooptu,B. and Lomas,D.A.
    Reactive centre loop mutants of alpha-1-antitrypsin reveal position-specific effects on intermediate formation along the polymerization pathway
    Biosci Rep33, e00046- PubMed  Europe PubMed DOI
  149. Izaguirre,G., Qi,L., Lima,M. and Olson,S.T.
    Identification of serpin determinants of specificity and selectivity for furin inhibition through studies of alpha1PDX (alpha1-protease inhibitor Portland)-serpin B8 and furin active-site loop chimeras
    J Biol Chem288, 21802-21814. PubMed  Europe PubMed DOI
  150. Laurell,C.B. and Eriksson,S.
    The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. 1963
    COPD10 Suppl 1, 3-8. PubMed  Europe PubMed DOI  M
  151. Lee,K.J., Lee,S.M., Gil,J.Y., Kwon,O., Kim,J.Y., Park,S.J., Chung,H.S. and Oh,D.B.
    N-glycan analysis of human alpha1-antitrypsin produced in Chinese hamster ovary cells
    Glycoconj J30, 537-547. PubMed  Europe PubMed DOI  E
  152. Maddur,A.A., Swanson,R., Izaguirre,G., Gettins,P.G. and Olson,S.T.
    Kinetic intermediates en route to the final serpin-protease complex: studies of complexes of alpha1-protease inhibitor with trypsin
    J Biol Chem288, 32020-32035. PubMed  Europe PubMed DOI
  153. Mansuy-Aubert,V., Zhou,Q.L., Xie,X., Gong,Z., Huang,J.Y., Khan,A.R., Aubert,G., Candelaria,K., Thomas,S., Shin,D.J., Booth,S., Baig,S.M., Bilal,A., Hwang,D., Zhang,H., Lovell-Badge,R., Smith,S.R., Awan,F.R. and Jiang,Z.Y.
    Imbalance between neutrophil elastase and its inhibitor alpha1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure
    Cell Metab17, 534-548. PubMed  Europe PubMed DOI  I
  154. Mueller,C. and Flotte,T.R.
    Gene-based therapy for alpha-1 antitrypsin deficiency
    COPD10 Suppl 1, 44-49. PubMed  Europe PubMed DOI  U
  155. Sandhaus,R.A. and Stoller,J.K.
    Introduction to the 50th anniversary of the description of alpha-1 antitrypsin deficiency
    COPD10 Suppl 1, 1-2. PubMed  Europe PubMed DOI  M
  156. Stockley,R.A., Dirksen,A. and Stolk,J.
    Alpha-1 antitrypsin deficiency: The European experience
    COPD10 Suppl 1, 50-53. PubMed  Europe PubMed DOI  M
  157. Stoller,J.K. and Brantly,M.
    The challenge of detecting alpha-1 antitrypsin deficiency
    COPD10 Suppl 1, 26-34. PubMed  Europe PubMed DOI  M
  158. Wang,Z., Hilder,T.L., van der Drift,K., Sloan,J. and Wee,K.
    Structural characterization of recombinant alpha-1-antitrypsin expressed in a human cell line
    Anal Biochem437, 20-28. PubMed  Europe PubMed DOI  E
  159. Wewers,M.D. and Crystal,R.G.
    Alpha-1 antitrypsin augmentation therapy
    COPD10 Suppl 1, 64-67. PubMed  Europe PubMed DOI  M
  160. 2012
  161. Dolmer,K. and Gettins,P.G.
    How the serpin alpha1-proteinase inhibitor folds
    J Biol Chem287, 12425-12432. PubMed  Europe PubMed DOI
  162. Enewold,L., Mechanic,L.E., Bowman,E.D., Platz,E.A. and Alberg,A.J.
    SERPINA1 and ELA2 Polymorphisms Are Not Associated with COPD or Lung Cancer
    Anticancer Res32, 3923-3928. PubMed  Europe PubMed  M
  163. Kass,I., Knaupp,A.S., Bottomley,S.P. and Buckle,A.M.
    Conformational properties of the disease-causing Z variant of alpha1-antitrypsin revealed by theory and experiment
    Biophys J102, 2856-2865. PubMed  Europe PubMed DOI  M
  164. McNab,G.L., Dafforn,T.R., Wood,A., Sapey,E. and Stockley,R.A.
    A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency
    Mamm Genome23, 241-249. PubMed  Europe PubMed DOI  M
  165. Miravitlles,M.
    Alpha-1-antitrypsin and other proteinase inhibitors
    Curr Opin Pharmacol12, 309-314. PubMed  Europe PubMed DOI  U
  166. Nyon,M.P., Kirkpatrick,J., Cabrita,L.D., Christodoulou,J. and Gooptu,B.
    1H, 15N and 13C backbone resonance assignments of the archetypal serpin alpha1-antitrypsin
    Biomol NMR Assign6, 153-156. PubMed  Europe PubMed DOI  S
  167. Qamar,A.A., Burke,S.K., Lafleur,J.D., Ding,B.C., Bland,K.S., Wong,M.D., Gustafson,P.N., Blair,A.T. and Franano,F.N.
    The ability of serum from alpha 1-antitrypsin-deficient patients to inhibit PRT-201, a recombinant human type I pancreatic elastase
    Biotechnol Appl Biochem59, 22-28. PubMed  Europe PubMed DOI
  168. Ross,D., Brown,T., Harper,R., Pamarthi,M., Nixon,J., Bromirski,J., Li,C.M., Ghali,R., Xie,H., Medvedeff,G., Li,H., Scuderi,P., Arora,V., Hunt,J. and Barnett,T.
    Production and characterization of a novel human recombinant alpha-1-antitrypsin in PER.C6 cells
    J Biotechnol162, 262-273. PubMed  Europe PubMed DOI  E
  169. Saunders,D.N., Tindall,E.A., Shearer,R.F., Roberson,J., Decker,A., Wilson,J.A. and Hayes,V.M.
    A novel SERPINA1 mutation causing serum alpha(1)-antitrypsin deficiency
    PLoS ONE7, e51762-e51762. PubMed  Europe PubMed DOI  M
  170. Sclar,D.A., Evans,M.A., Robison,L.M. and Skaer,T.L.
    alpha1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to alpha1-antitrypsin deficiency: number and costs of years of life gained
    Clin Drug Investig32, 353-360. PubMed  Europe PubMed DOI  U
  171. Stocks,B.B., Sarkar,A., Wintrode,P.L. and Konermann,L.
    Early hydrophobic collapse of alpha1-antitrypsin facilitates formation of a metastable state: insights from oxidative labeling and mass spectrometry
    J Mol Biol423, 789-799. PubMed  Europe PubMed DOI
  172. Tsutsui,Y., Dela Cruz,R. and Wintrode,P.L.
    Folding mechanism of the metastable serpin alpha1-antitrypsin
    Proc Natl Acad Sci U S A109, 4467-4472. PubMed  Europe PubMed DOI
  173. Wang,Y., He,Y., Abraham,B., Rouhani,F.N., Brantly,M.L., Scott,D.E. and Reed,J.L.
    Cytosolic, autocrine alpha-1 proteinase inhibitor (A1PI) inhibits caspase-1 and blocks IL-1beta dependent cytokine release in monocytes
    PLoS ONE7, e51078-e51078. PubMed  Europe PubMed DOI
  174. Zhang,L., Shi,J., Jiang,D., Stupak,J., Ou,J., Qiu,Q., An,N., Li,J. and Yang,D.
    Expression and characterization of recombinant human alpha-antitrypsin in transgenic rice seed
    J Biotechnol164, 300-308. PubMed  Europe PubMed DOI  E
  175. 2011
  176. Dickens,J.A. and Lomas,D.A.
    Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis
    Drug Des Devel Ther5, 391-405. PubMed  Europe PubMed DOI  U
  177. Flotte,T.R. and Mueller,C.
    Gene therapy for alpha-1 antitrypsin deficiency
    Hum Mol Genet20, R87-R92. PubMed  Europe PubMed DOI  U
  178. Gierczak,R.F., Sutherland,J.S., Bhakta,V., Toltl,L.J., Liaw,P.C. and Sheffield,W.P.
    Retention of thrombin inhibitory activity by recombinant serpins expressed as integral membrane proteins tethered to the surface of mammalian cells
    J Thromb Haemost9, 2424-2435. PubMed  Europe PubMed DOI
  179. Huntington,J.A.
    Serpin structure, function and dysfunction
    J Thromb Haemost9 Suppl 1, 26-34. PubMed  Europe PubMed DOI  S
  180. Janciauskiene,S.M., Bals,R., Koczulla,R., Vogelmeier,C., Kohnlein,T. and Welte,T.
    The discovery of alpha1-antitrypsin and its role in health and disease
    Respir Med105, 1129-1139. PubMed  Europe PubMed DOI  V
  181. Knaupp,A.S. and Bottomley,S.P.
    Structural change in beta-sheet A of Z alpha(1)-antitrypsin is responsible for accelerated polymerization and disease
    J Mol Biol413, 888-898. PubMed  Europe PubMed DOI  M
  182. Krishnan,B. and Gierasch,L.M.
    Dynamic local unfolding in the serpin alpha-1 antitrypsin provides a mechanism for loop insertion and polymerization
    Nat Struct Mol Biol18, 222-226. PubMed  Europe PubMed DOI
  183. Maciejewska-Radomska,A. and Wilkowska,A.
    Panniculitis as a rare clinical manifestation of genetically determined abnormalities of alpha I-antitrypsin - review of the literature
    Prz Dermatol98, 350-354.  M  V
  184. Patschull,A.O., Segu,L., Nyon,M.P., Lomas,D.A., Nobeli,I., Barrett,T.E. and Gooptu,B.
    Therapeutic target-site variability in alpha1-antitrypsin characterized at high resolution
    Acta Crystallogr Sect F Struct Biol Cryst Commun67, 1492-1497. PubMed  Europe PubMed DOI  S
  185. Perez,P., Adriaansen,J., Goldsmith,C.M., Zheng,C. and Baum,B.J.
    Transgenic alpha-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active
    Oral Dis17, 476-483. PubMed  Europe PubMed DOI  U
  186. Sarkar,A. and Wintrode,P.L.
    Effects of glycosylation on the stability and flexibility of a metastable protein: the human serpin alpha1-antitrypsin
    Int J Mass Spectrom302, 69-75. PubMed  Europe PubMed DOI
  187. Thelwell,C., Marszal,E., Rigsby,P. and Longstaff,C.
    An international collaborative study to establish the WHO 1st international standard for alpha-1-antitrypsin
    Vox Sang101, 83-89. PubMed  Europe PubMed DOI  U
  188. Vukoti,K.M., Kadiyala,C.S. and Miyagi,M.
    Streptomyces erythraeus trypsin inactivates alpha1-antitrypsin
    FEBS Lett585, 3898-3902. PubMed  Europe PubMed DOI
  189. Wang,D., Wang,W., Dawkins,P., Paterson,T., Kalsheker,N., Sallenave,J.M. and McGarry Houghton,A.
    Deletion of serpina1a, a murine alpha1-antitrypsin ortholog, results in embryonic lethality
    Exp Lung Res37, 291-300. PubMed  Europe PubMed DOI  K
  190. Yamasaki,M., Sendall,T.J., Pearce,M.C., Whisstock,J.C. and Huntington,J.A.
    Molecular basis of alpha1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer
    EMBO Rep12, 1011-1017. PubMed  Europe PubMed DOI  M
  191. 2010
  192. Agarwal,S., Jha,S., Sanyal,I. and Amla,D.V.
    Expression and purification of recombinant human alpha1-proteinase inhibitor and its single amino acid substituted variants in Escherichia coli for enhanced stability and biological activity
    J Biotechnol147, 64-72. PubMed  Europe PubMed DOI  E
  193. Huntington,J.A. and Whisstock,J.C.
    Molecular contortionism - on the physical limits of serpin 'loop-sheet' polymers
    Biol Chem391, 973-982. PubMed  Europe PubMed DOI
  194. Kilty,S.J., Bosse,Y., Cormier,C., Endam,L.M. and Desrosiers,M.Y.
    Polymorphisms in the SERPINA1 (alpha-1-antitrypsin) gene are associated with severe chronic rhinosinusitis unresponsive to medical therapy
    Am J Rhinol Allergy24, e4-e9. PubMed  Europe PubMed DOI  M
  195. Knaupp,A.S., Levina,V., Robertson,A.L., Pearce,M.C. and Bottomley,S.P.
    Kinetic instability of the serpin Z alpha1-antitrypsin promotes aggregation
    J Mol Biol396, 375-383. PubMed  Europe PubMed DOI  M
  196. Ratner,M.
    Cochrane meta-analysis on alpha-1 antitrypsin prompts furor
    Nat Biotechnol28, 885-886. PubMed  Europe PubMed DOI  U
  197. Yamasaki,M., Sendall,T.J., Harris,L.E., Lewis,G.M. and Huntington,J.A.
    Loop-sheet mechanism of serpin polymerization tested by reactive center loop mutations
    J Biol Chem285, 30752-30758. PubMed  Europe PubMed DOI
  198. 2009
  199. Baek,J.H., Yang,W.S., Lee,C. and Yu,M.H.
    Functional unfolding of alpha1-antitrypsin probed by hydrogen-deuterium exchange coupled with mass spectrometry
    Mol Cell Proteomics8, 1072-1081. PubMed  Europe PubMed DOI
  200. Chill,L., Trinh,L., Azadi,P., Ishihara,M., Sonon,R., Karnaukhova,E., Ophir,Y., Golding,B. and Shiloach,J.
    Production, purification, and characterization of human alpha1 proteinase inhibitor from Aspergillus niger
    Biotechnol Bioeng102, 828-844. PubMed  Europe PubMed DOI  E
  201. Gooptu,B., Miranda,E., Nobeli,I., Mallya,M., Purkiss,A., Brown,S.C., Summers,C., Phillips,R.L., Lomas,D.A. and Barrett,T.E.
    Crystallographic and cellular characterisation of two mechanisms stabilising the native fold of alpha1-antitrypsin: implications for disease and drug design
    J Mol Biol387, 857-868. PubMed  Europe PubMed DOI  S
  202. Levina,V., Dai,W., Knaupp,A.S., Kaiserman,D., Pearce,M.C., Cabrita,L.D., Bird,P.I. and Bottomley,S.P.
    Expression, purification and characterization of recombinant Z alpha(1)-antitrypsin - the most common cause of alpha(1)-antitrypsin deficiency
    Protein Expr Purif68, 226-232. PubMed  Europe PubMed DOI  E  M
  203. Maisa,A., Stroher,U., Klenk,H.D., Garten,W. and Strecker,T.
    Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants
    PLoS Negl Trop Dis3, e446-e446. PubMed  Europe PubMed DOI
  204. Mickowska,B.
    Purification and characterization of alpha(1)-proteinase inhibitor and antithrombin III: major serpins of rainbow trout (Oncorhynchuss mykiss) and carp (Cyprinus carpio) blood plasma
    Fish Physiol Biochem35, 231-240. PubMed  Europe PubMed DOI
  205. Nadai,M., Bally,J., Vitel,M., Job,C., Tissot,G., Botterman,J. and Dubald,M.
    High-level expression of active human alpha1-antitrypsin in transgenic tobacco chloroplasts
    Transgenic Res18, 173-183. PubMed  Europe PubMed DOI  E
  206. Sengupta,T., Tsutsui,Y. and Wintrode,P.L.
    Local and global effects of a cavity filling mutation in a metastable serpin
    Biochemistry48, 8233-8240. PubMed  Europe PubMed DOI
  207. 2008
  208. Fregonese,L., Stolk,J., Frants,R.R. and Veldhuisen,B.
    Alpha-1 antitrypsin Null mutations and severity of emphysema
    Respir Med102, 876-884. PubMed  Europe PubMed DOI  M
  209. Matthiessen,H.P., Willemse,J., Weber,A., Turecek,P.L., Deiteren,K., Hendriks,D., Ehrlich,H.J. and Schwarz,H.P.
    Ethanol dependence of alpha1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases
    Transfusion48, 314-320. PubMed  Europe PubMed DOI
  210. Pearce,M.C., Morton,C.J., Feil,S.C., Hansen,G., Adams,J.J., Parker,M.W. and Bottomley,S.P.
    Preventing serpin aggregation: the molecular mechanism of citrate action upon antitrypsin unfolding
    Protein Sci17, 2127-2133. PubMed  Europe PubMed DOI  S
  211. Prins,J., van der Meijden,B.B., Kraaijenhagen,R.J. and Wielders,J.P.
    Inherited chronic obstructive pulmonary disease: new selective-sequencing workup for alpha1-antitrypsin deficiency identifies 2 previously unidentified null alleles
    Clin Chem54, 101-107. PubMed  Europe PubMed DOI  M
  212. Sandhaus,R.A., Turino,G., Stocks,J., Strange,C., Trapnell,B.C., Silverman,E.K., Everett,S.E. and Stoller,J.K.
    alpha1-antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note
    Chest134, 831-834. PubMed  Europe PubMed DOI
  213. 2007
  214. Baek,J.H., Im,H., Kang,U.B., Seong,K.M., Lee,C., Kim,J. and Yu,M.H.
    Probing the local conformational change of alpha1-antitrypsin
    Protein Sci16, 1842-1850. PubMed  Europe PubMed DOI
  215. Chowdhury,P., Wang,W., Lavender,S., Bunagan,M.R., Klemke,J.W., Tang,J., Saven,J.G., Cooperman,B.S. and Gai,F.
    Fluorescence correlation spectroscopic study of serpin depolymerization by computationally designed peptides
    J Mol Biol369, 462-473. PubMed  Europe PubMed DOI
  216. Cruz,P.E., Mueller,C. and Flotte,T.R.
    The promise of gene therapy for the treatment of alpha-1 antitrypsin deficiency
    Pharmacogenomics8, 1191-1198. PubMed  Europe PubMed DOI
  217. Kaczor,M.P., Sanak,M. and Szczeklik,A.
    Rapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a large-scale population-based screening
    J Mol Diagn9, 99-104. PubMed  Europe PubMed DOI
  218. Karnaukhova,E., Ophir,Y., Trinh,L., Dalal,N., Punt,P.J., Golding,B. and Shiloach,J.
    Expression of human alpha1-proteinase inhibitor in Aspergillus niger
    Microb Cell Fact6, 34-34. PubMed  Europe PubMed DOI  E
  219. Liu,L., Mushero,N., Hedstrom,L. and Gershenson,A.
    Short-lived protease serpin complexes: Partial disruption of the rat trypsin active site
    Protein Sci16, 2403-2411. PubMed  Europe PubMed DOI
  220. Mordwinkin,N.M. and Louie,S.G.
    Aralast: an alpha1-protease inhibitor for the treatment of alpha-antitrypsin deficiency
    Expert Opin Pharmacother8, 2609-2614. PubMed  Europe PubMed DOI  U
  221. Mulgrew,A.T., Taggart,C.C. and McElvaney,N.G.
    Alpha-1-antitrypsin deficiency: current concepts
    Lung185, 191-201. PubMed  Europe PubMed DOI  M  V
  222. Tsuji,A., Kanie,H., Makise,H., Yuasa,K., Nagahama,M. and Matsuda,Y.
    Engineering of alpha1-antitrypsin variants selective for subtilisin-like proprotein convertases PACE4 and PC6: importance of the P2' residue in stable complex formation of the serpin with proprotein convertase
    Protein Eng Des Sel20, 163-170. PubMed  Europe PubMed DOI
  223. Tsutsui,Y. and Wintrode,P.L.
    Cooperative unfolding of a metastable serpin to a molten globule suggests a link between functional and folding energy landscapes
    J Mol Biol371, 245-255. PubMed  Europe PubMed DOI
  224. Weber,A., Engelmaier,A., Owen,M.C., Schwarz,H.P. and Turecek,P.L.
    Convenient high-resolution isoelectric focusing (IEF) method for the separation of alpha1-proteinase inhibitor (A1PI) isoforms in A1PI concentrates
    J Pharm Biomed Anal45, 107-111. PubMed  Europe PubMed DOI
  225. Wood,A.M. and Stockley,R.A.
    Alpha one antitrypsin deficiency: from gene to treatment
    Respiration74, 481-492. PubMed  Europe PubMed DOI  V
  226. 2006
  227. Chang,Y.P., Mahadeva,R., Chang,W.S., Shukla,A., Dafforn,T.R. and Chu,Y.H.
    Identification of a 4-mer peptide inhibitor that effectively blocks the polymerization of pathogenic Z alpha1-antitrypsin
    Am J Respir Cell Mol Biol35, 540-548. PubMed  Europe PubMed DOI
  228. Dementiev,A., Dobo,J. and Gettins,P.G.
    Active site distortion is sufficient for proteinase inhibition by serpins: structure of the covalent complex of alpha1-proteinase inhibitor with porcine pancreatic elastase
    J Biol Chem281, 3452-3457. PubMed  Europe PubMed DOI  S
  229. Karnaukhova,E., Ophir,Y. and Golding,B.
    Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use
    Amino Acids30, 317-332. PubMed  Europe PubMed DOI  E
  230. Kolarich,D., Turecek,P.L., Weber,A., Mitterer,A., Graninger,M., Matthiessen,P., Nicolaes,G.A., Altmann,F. and Schwarz,H.P.
    Biochemical, molecular characterization, and glycoproteomic analyses of alpha(1)-proteinase inhibitor products used for replacement therapy
    Transfusion46, 1959-1977. PubMed  Europe PubMed DOI  U
  231. [YEAR:15-5-2006]Lomas,D.A.
    The selective advantage of alpha1-antitrypsin deficiency
    Am J Respir Crit Care Med173, 1072-1077. PubMed  Europe PubMed DOI
  232. Martin,S.L., Downey,D., Bilton,D., Keogan,M.T., Edgar,J. and Elborn,J.S.
    Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis
    Pediatr Pulmonol41, 177-183. PubMed  Europe PubMed DOI
  233. Pemberton,P.A., Kobayashi,D., Wilk,B.J., Henstrand,J.M., Shapiro,S.D. and Barr,P.J.
    Inhaled recombinant alpha 1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse
    COPD3, 101-108. PubMed  Europe PubMed DOI
  234. Stocks,J.M., Brantly,M., Pollock,D., Barker,A., Kueppers,F., Strange,C., Donohue,J.F. and Sandhaus,R.
    Multi-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, Zemaira
    COPD3, 17-23. PubMed  Europe PubMed DOI
  235. [YEAR:26-9-2006]Sutherland,J.S., Bhakta,V., Filion,M.L. and Sheffield,W.P.
    The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition
    Biochemistry45, 11444-11452. PubMed  Europe PubMed DOI
  236. [YEAR:30-5-2006]Tsutsui,Y., Liu,L., Gershenson,A. and Wintrode,P.L.
    The conformational dynamics of a metastable serpin studied by hydrogen exchange and mass spectrometry
    Biochemistry45, 6561-6569. PubMed  Europe PubMed DOI
  237. Zimmerman,T.P.
    Yield improvement for manufacture of alpha-proteinase inhibitor
    Vox Sang91, 309-315. PubMed  Europe PubMed DOI  E
  238. 2005
  239. Abboud,R.T., Ford,G.T. and Chapman,K.R.
    Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Treat Respir Med4, 1-8. PubMed  Europe PubMed DOI
  240. Khatib,H.
    Monoallelic expression of the protease inhibitor gene in humans, sheep, and cattle
    Mamm Genome16, 50-58. PubMed  Europe PubMed DOI  M
  241. Louie,S.G., Sclar,D.A. and Gill,M.A.
    Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency
    Ann Pharmacother39, 1861-1869. PubMed  Europe PubMed DOI
  242. [YEAR:31-1-2005]Nita,I., Hollander,C., Westin,U. and Janciauskiene,S.M.
    Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release
    Respir Res6, 12-12. PubMed  Europe PubMed DOI
  243. [YEAR:10-6-2005]Ray,S., Mickleborough,T.D. and Brown,J.L.
    Comparison of the properties of rare variants of alpha1-proteinase inhibitor expressed in COS-1 cells and assessment of their potential as risk factors in human disease
    Biochim Biophys Acta Mol Basis Dis1740, 390-402. PubMed  Europe PubMed DOI  M
  244. 2004
  245. Blanco,I., Canto,H., de Serres,F.J., Fernandez-Bustillo,E. and Rodriguez,M.C.
    Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency
    J Rheumatol31, 2082-2085. PubMed  Europe PubMed
  246. Carrell,R.W.
    What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell
    COPD1, 71-84. PubMed  Europe PubMed DOI  V
  247. Chappell,S., Guetta-Baranes,T., Batowski,K., Yiannakis,E., Morgan,K., O'Connor,C., MacNee,W. and Kalsheker,N.
    Haplotypes of the alpha-1 antitrypsin gene in healthy controls and Z deficiency patients
    Hum Mutat24, 535-536. PubMed  Europe PubMed DOI  M
  248. Crowther,D.C., Belorgey,D., Miranda,E., Kinghorn,K.J., Sharp,L.K. and Lomas,D.A.
    Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies
    Eur J Hum Genet12, 167-172. PubMed  Europe PubMed DOI  M
  249. Dobo,J. and Gettins,P.G.
    alpha1-Proteinase inhibitor forms initial non-covalent and final covalent complexes with elastase analogously to other serpin-proteinase pairs, suggesting a common mechanism of inhibition
    J Biol Chem279, 9264-9269. PubMed  Europe PubMed DOI
  250. [YEAR:23-11-2004]Filion,M.L., Bhakta,V., Nguyen,L.H., Liaw,P.S. and Sheffield,W.P.
    Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition
    Biochemistry43, 14864-14872. PubMed  Europe PubMed DOI
  251. Jung,C.H., Na,Y.R. and Im,H.
    Retarded protein folding of deficient human alpha 1-antitrypsin D256V and L41P variants
    Protein Sci13, 694-702. PubMed  Europe PubMed DOI
  252. [YEAR:17-12-2004]Jung,C.H., Chae,Y.K. and Im,H.
    Suppression of the facile latency transition of alpha(1)-antitrypsin variant M(malton) by stabilizing mutations
    Biochem Biophys Res Commun325, 744-750. PubMed  Europe PubMed DOI
  253. [YEAR:15-10-2004]Kang,U.B., Baek,J.H., Ryu,S.H., Kim,J., Yu,M.H. and Lee,C.
    Kinetic mechanism of protease inhibition by alpha1-antitrypsin
    Biochem Biophys Res Commun323, 409-415. PubMed  Europe PubMed DOI
  254. [YEAR:1-12-2004]Li,W., Savinov,A.Y., Rozanov,D.V., Golubkov,V.S., Hedayat,H., Postnova,T.I., Golubkova,N.V., Linli,Y., Krajewski,S. and Strongin,A.Y.
    Matrix metalloproteinase-26 is associated with estrogen-dependent malignancies and targets alpha1-antitrypsin serpin
    Cancer Res64, 8657-8665. PubMed  Europe PubMed DOI
  255. Luisetti,M. and Seersholm,N.
    Alpha1-antitrypsin deficiency. 1: Epidemiology of alpha1-antitrypsin deficiency
    Thorax59, 164-169. PubMed  Europe PubMed DOI
  256. Mulgrew,A.T., Taggart,C.C., Lawless,M.W., Greene,C.M., Brantly,M.L., O'Neill,S.J. and McElvaney,N.G.
    Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant
    Chest125, 1952-1957. PubMed  Europe PubMed DOI  M
  257. [YEAR:10-6-2004]Nie,J. and Pei,D.
    Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6
    Exp Cell Res296, 145-150. PubMed  Europe PubMed DOI
  258. Parfrey,H., Dafforn,T.R., Belorgey,D., Lomas,D.A. and Mahadeva,R.
    Inhibiting polymerization: new therapeutic strategies for Z alpha1-antitrypsin-related emphysema
    Am J Respir Cell Mol Biol31, 133-139. PubMed  Europe PubMed DOI
  259. [YEAR:16-2-2004]Pullikotil,P., Vincent,M., Nichol,S.T. and Seidah,N.G.
    Development of protein-based inhibitors of the proprotein of convertase SKI-1/S1P: processing of SREBP-2, ATF6, and a viral glycoprotein
    J Biol Chem279, 17338-17347. PubMed  Europe PubMed DOI
  260. 2003
  261. [YEAR:15-2-2003]Bousquet,J.A., Duranton,J., Mely,Y. and Bieth,J.G.
    Conformational change in elastase following complexation with alpha1-proteinase inhibitor: a CD investigation
    Biochem J370, 345-349. PubMed  Europe PubMed DOI
  262. de Serres,F.J.
    Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed
    Environ Health Perspect111, 1851-1854. PubMed  Europe PubMed
  263. [YEAR:26-9-2003]Dementiev,A., Simonovic,M., Volz,K. and Gettins,P.G.
    Canonical inhibitor-like interactions explain reactivity of alpha1-proteinase inhibitor Pittsburgh and antithrombin with proteinases
    J Biol Chem278, 37881-37887. PubMed  Europe PubMed DOI  M  S
  264. Duranton,J. and Bieth,J.G.
    Inhibition of proteinase 3 by [alpha]1-antitrypsin in vitro predicts very fast inhibition in vivo
    Am J Respir Cell Mol Biol29, 57-61. PubMed  Europe PubMed DOI
  265. Forsyth,S., Horvath,A. and Coughlin,P.
    A review and comparison of the murine alpha1-antitrypsin and alpha1-antichymotrypsin multigene clusters with the human clade A serpins
    Genomics81, 336-345. PubMed  Europe PubMed DOI
  266. [YEAR:30-5-2003]Marszal,E., Danino,D. and Shrake,A.
    A novel mode of polymerization of alpha1-proteinase inhibitor
    J Biol Chem278, 19611-19618. PubMed  Europe PubMed DOI  M
  267. [YEAR:29-8-2003]Parfrey,H., Mahadeva,R., Ravenhill,N.A., Zhou,A., Dafforn,T.R., Foreman,R.C. and Lomas,D.A.
    Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease
    J Biol Chem278, 33060-33066. PubMed  Europe PubMed DOI  M
  268. [YEAR:27-2-2003]Wilczynska,M., Lobov,S. and Ny,T.
    The spontaneous polymerization of plasminogen activator inhibitor type-2 and Z-antitrypsin are due to different molecular aberrations
    FEBS Lett537, 11-16. PubMed  Europe PubMed DOI  M
  269. 2002
  270. Barbour,K.W., Goodwin,R.L., Guillonneau,F., Wang,Y., Baumann,H. and Berger,F.G.
    Functional diversification during evolution of the murine alpha(1)-proteinase inhibitor family: role of the hypervariable reactive center loop
    Mol Biol Evol19, 718-727. PubMed  Europe PubMed
  271. Barbour,K.W., Wei,F., Brannan,C., Flotte,T.R., Baumann,H. and Berger,F.G.
    The murine alpha(1)-proteinase inhibitor gene family: polymorphism, chromosomal location, and structure
    Genomics80, 515-522. PubMed  Europe PubMed DOI  M
  272. Cantin,A.M., Woods,D.E., Cloutier,D., Dufour,E.K. and Leduc,R.
    Polyethylene glycol conjugation at Cys232 prolongs the half-life of alpha1 proteinase inhibitor
    Am J Respir Cell Mol Biol27, 659-665. PubMed  Europe PubMed DOI
  273. Chowanadisai,W. and Lonnerdal,B.
    Alpha(1)-antitrypsin and antichymotrypsin in human milk: origin, concentrations, and stability
    Am J Clin Nutr76, 828-833. PubMed  Europe PubMed
  274. Im,H., Woo,M.S., Hwang,K.Y. and Yu,M.H.
    Interactions causing the kinetic trap in serpin protein folding
    J Biol Chem277, 46347-46354. PubMed  Europe PubMed DOI  S
  275. [YEAR:16-4-2002]Irving,J.A., Pike,R.N., Dai,W., Bromme,D., Worrall,D.M., Silverman,G.A., Coetzer,T.H., Dennison,C., Bottomley,S.P. and Whisstock,J.C.
    Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases
    Biochemistry41, 4998-5004. PubMed  Europe PubMed DOI
  276. Lomas,D.A., Lourbakos,A., Cumming,S.A. and Belorgey,D.
    Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia
    Biochem Soc Trans30, 89-92. PubMed  Europe PubMed
  277. [YEAR:1-3-2002]Mahadeva,R., Dafforn,T.R., Carrell,R.W. and Lomas,D.A.
    6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis
    J Biol Chem277, 6771-6774. PubMed  Europe PubMed DOI
  278. [YEAR:11-10-2002]Mellet,P., Mely,Y., Hedstrom,L., Cahoon,M., Belorgey,D., Srividya,N., Rubin,H. and Bieth,J.G.
    Comparative trajectories of active and S195A inactive trypsin upon binding to serpins
    J Biol Chem277, 38901-38914. PubMed  Europe PubMed DOI
  279. [YEAR:15-9-2002]Rodriguez,F., Jardi,R., Costa,X., Cotrina,M., Galimany,R., Vidal,R. and Miravitlles,M.
    Rapid screening for alpha1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood specimens
    Am J Respir Crit Care Med166, 814-817. PubMed  Europe PubMed DOI
  280. Sandoval,C., Curtis,H. and Congote,L.F.
    Enhanced proliferative effects of a baculovirus-produced fusion protein of insulin-like growth factor and alpha(1)-proteinase inhibitor and improved anti-elastase activity of the inhibitor with glutamate at position 351
    Protein Eng15, 413-418. PubMed  Europe PubMed
  281. Stoller,J.K., Rouhani,F., Brantly,M., Shahin,S., Dweik,R.A., Stocks,J.M., Clausen,J., Campbell,E. and Norton,F.
    Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin
    Chest122, 66-74. PubMed  Europe PubMed DOI
  282. Sulikowski,T., Bauer,B.A. and Patston,P.A.
    alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1
    Protein Sci11, 2230-2236. PubMed  Europe PubMed DOI
  283. Tsuji,A., Ikoma,T., Hashimoto,E. and Matsuda,Y.
    Development of selectivity of alpha1-antitrypsin variant by mutagenesis in its reactive site loop against proprotein convertase. A crucial role of the P4 arginine in PACE4 inhibition
    Protein Eng15, 123-130. PubMed  Europe PubMed
  284. 2001
  285. Gladysheva,I.P., Popykina,N.A., Zamolodchikova,T.S. and Larionova,N.I.
    Interaction between duodenase and alpha1-proteinase inhibitor
    Biochemistry (Mosc)66, 682-687. PubMed  Europe PubMed DOI
  286. Kim,S., Woo,J., Seo,E.J., Yu,M. and Ryu,S.
    A 2.1 A resolution structure of an uncleaved alpha(1)-antitrypsin shows variability of the reactive center and other loops
    J Mol Biol306, 109-119. PubMed  Europe PubMed DOI  S
  287. Kropp,J., Wencker,M., Hotze,A., Banik,N., Hubner,G.E., Wunderlich,G., Ulbrich,E., Konietzko,N. and Biersack,H.J.
    Inhalation of [123I]alpha1-protease inhibitor: Toward a new therapeutic concept of alpha1-protease inhibitor deficiency?
    J Nucl Med42, 744-751. PubMed  Europe PubMed
  288. [YEAR:29-5-2001]Peterson,F.C. and Gettins,P.G.
    Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha1-proteinase inhibitor Pittsburgh-trypsin covalent complex
    Biochemistry40, 6284-6292. PubMed  Europe PubMed DOI
  289. [YEAR:6-4-2001]Tew,D.J. and Bottomley,S.P.
    Intrinsic fluorescence changes and rapid kinetics of proteinase deformation during serpin inhibition
    FEBS Lett494, 30-33. PubMed  Europe PubMed DOI
  290. 2000
  291. Dunstone,M.A., Dai,W., Whisstock,J.C., Rossjohn,J., Pike,R.N., Feil,S.C., le Bonniec,B.F., Parker,M.W. and Bottomley,S.P.
    Cleaved antitrypsin polymers at atomic resolution
    Protein Sci9, 417-420. PubMed  Europe PubMed DOI  S
  292. [YEAR:3-10-2000]Peterson,F.C., Gordon,N.C. and Gettins,P.G.
    Formation of a noncovalent serpin-proteinase complex involves no conformational change in the serpin. Use of 1H-15N HSQC NMR as a sensitive nonperturbing monitor of conformation
    Biochemistry39, 11884-11892. PubMed  Europe PubMed DOI
  293. 1999
  294. Huntington,J.A., Pannu,N.S., Hazes,B., Read,R.J., Lomas,D.A. and Carrell,R.W.
    A 2.6 A structure of a serpin polymer and implications for conformational disease
    J Mol Biol293, 449-455. PubMed  Europe PubMed DOI  S
  295. Rapala-Kozik,M., Potempa,J., Nelson,D., Kozik,A. and Travis,J.
    Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases
    Biol Chem380, 1211-1216. PubMed  Europe PubMed DOI
  296. Tsuji,A., Hashimoto,E., Ikoma,T., Taniguchi,T., Mori,K., Nagahama,M. and Matsuda,Y.
    Inactivation of proprotein convertase, PACE4, by alpha1-antitrypsin Portland (alpha1-PDX), a blocker of proteolytic activation of bone morphogenetic protein during embryogenesis: evidence that PACE4 is able to form an SDS-stable acyl intermediate with alpha1-PDX
    J Biochem126, 591-603. PubMed  Europe PubMed  I
  297. 1998
  298. [YEAR:10-4-1998]Dufour,E.K., Denault,J.B., Hopkins,P.C. and Leduc,R.
    Serpin-like properties of alpha1-antitrypsin Portland towards furin convertase
    FEBS Lett426, 41-46. PubMed  Europe PubMed
  299. [YEAR:23-1-1998]Elliott,P.R., Abrahams,J.P. and Lomas,D.A.
    Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation
    J Mol Biol275, 419-425. PubMed  Europe PubMed DOI
  300. Jean,F., Stella,K., Thomas,L., Liu,G., Xiang,Y., Reason,A.J. and Thomas,G.
    alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent
    Proc Natl Acad Sci U S A95, 7293-7298. PubMed  Europe PubMed DOI  M  I
  301. 1997
  302. Cook,L., Knight,K.R., Burdon,J.G.W., Brenton,S. and Hunt,J.M.
    Function of a rare variant of alpha-1-antitrypsin, phenotype Pi E(Franklin) S, a poor inhibitor of human neutrophil elastase
    Res Exp Med (Berl)196, 355-362. PubMed  Europe PubMed DOI  M
  303. Kaslik,G., Kardos,J., Szabo,E., Szilagyi,L., Zavodszky,P., Westler,W.M., Markley,J.L. and Graf,L.
    Effects of serpin binding on the target proteinase: global stabilization, localized increased structural flexibility, and conserved hydrogen bonding at the active site
    Biochemistry36, 5455-5464. PubMed  Europe PubMed DOI
  304. Mains,R.E., Berard,C.A., Denault,J.B., Zhou,A., Johnson,R.C. and Leduc,R.
    PACE4: a subtilisin-like endoprotease with unique properties
    Biochem J321, 587-593. PubMed  Europe PubMed  I
  305. 1996
  306. Elliott,P.R., Lomas,D.A., Carrell,R.W. and Abrahams,J.P.
    Inhibitory conformation of the reactive loop of alpha 1-antitrypsin
    Nat Struct Biol3, 676-681. PubMed  Europe PubMed DOI  S
  307. Goodwin,R.L., Baumann,H. and Berger,F.G.
    Patterns of divergence during evolution of alpha 1-proteinase inhibitors in mammals
    Mol Biol Evol13, 346-358. PubMed  Europe PubMed
  308. Ryu,S.E., Choi,H.J., Kwon,K.S., Lee,K.N. and Yu,M.H.
    The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A
    Structure4, 1181-1192. PubMed  Europe PubMed  S
  309. 1995
  310. Song,H.K., Lee,K.N., Kwon,K.S., Yu,M.H. and Suh,S.W.
    Crystal structure of an uncleaved alpha 1-antitrypsin reveals the conformation of its inhibitory reactive loop
    FEBS Lett377, 150-154. PubMed  Europe PubMed DOI  S
  311. 1994
  312. Sires,U.I., Murphy,G., Baragi,V.M., Fliszar,C.J., Welgus,H.G. and Senior,R.M.
    Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha1-antitrypsin
    Biochem Biophys Res Commun204, 613-620. PubMed  Europe PubMed DOI
  313. [YEAR:2-3-1994]Zhang,Z., Winyard,P.G., Chidwick,K., Murphy,G., Wardell,M., Carrell,R.W. and Blake,D.R.
    Proteolysis of human native and oxidised alpha 1-proteinase inhibitor by matrilysin and stromelysin
    Biochim Biophys Acta1199, 224-228. PubMed  Europe PubMed DOI
  314. 1993
  315. Stoller,J.K., Hupertz,V. and Aboussouan,L.S.
    Alpha-1 Antitrypsin Deficiency
    PubMed  Europe PubMed
  316. 1992
  317. Chao,J., Chen,L.M., Chai,K.X. and Chao,L.
    Expression of kallikrein-binding protein and alpha 1-antitrypsin genes in response to sex hormones, growth, inflammation and hypertension
    Agents Actions Suppl38, 174-181. PubMed  Europe PubMed
  318. Imamura,T. and Kambara,T.
    The major plasma kallikrein inhibitor of guinea pig plasma
    Biochim Biophys Acta1118, 261-266. PubMed  Europe PubMed DOI
  319. Mast,A.E., Enghild,J.J. and Salvesen,G.
    Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis
    Biochemistry31, 2720-2728. PubMed  Europe PubMed  P
  320. Michaelis,J., Vissers,M.C. and Winterbourn,C.C.
    Cleavage of alpha 1-antitrypsin by human neutrophil collagenase
    Matrix Suppl1, 80-81. PubMed  Europe PubMed
  321. Schulze,A.J., Frohnert,P.W., Engh,R.A. and Huber,R.
    Evidence for the extent of insertion of the active site loop of intact alpha1 proteinase inhibitor in beta-sheet A
    Biochemistry31, 7560-7565. PubMed  Europe PubMed
  322. [YEAR:14-9-1992]Serveau,C., Moreau,T., Zhou,G.X., ElMoujahed,A., Chao,J. and Gauthier,F.
    Inhibition of rat tissue kallikrein gene family members by rat kallikrein-binding protein and alpha 1-proteinase inhibitor
    FEBS Lett309, 405-408. PubMed  Europe PubMed DOI
  323. Suzuki,Y. and Sinohara,H.
    Molecular evolution and acute phase change of guinea pig contrapsin and alpha-1-antiproteinase
    Folia Histochem Cytobiol30, 191-193. PubMed  Europe PubMed
  324. 1991
  325. Frommherz,K.J., Faller,B. and Bieth,J.G.
    Heparin strongly decreases the rate of inhibition of neutrophil elastase by alpha1-proteinase inhibitor
    J Biol Chem266, 15356-15362. PubMed  Europe PubMed
  326. Mast,A.E., Enghild,J.J., Nagase,H., Suzuki,K., Pizzo,S.V. and Salvesen,G.
    Kinetics and physiologic relevance of the inactivation of alpha1- proteinase inhibitor, alpha1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin)
    J Biol Chem266, 15810-15816. PubMed  Europe PubMed
  327. Schulze,A.J., Huber,R., Degryse,E., Speck,D. and Bischoff,R.
    Inhibitory activity and conformational transition of alpha1-proteinase inhibitor variants
    Eur J Biochem202, 1147-1155. PubMed  Europe PubMed  S
  328. [YEAR:15-1-1991]Suzuki,Y., Yoshida,K., Honda,E. and Sinohara,H.
    Molecular cloning and sequence analysis of cDNAs coding for guinea pig alpha 1-antiproteinases S and F and contrapsin
    J Biol Chem266, 928-932. PubMed  Europe PubMed
  329. 1990
  330. [YEAR:24-4-1990]Knauper,V., Reinke,H. and Tschesche,H.
    Inactivation of human plasma alpha1-proteinase inhibitor by human PMN leucocyte collagenase
    FEBS Lett263, 355-357. PubMed  Europe PubMed DOI
  331. [YEAR:31-8-1990]Misumi,Y., Ohkubo,K., Sohda,M., Takami,N., Oda,K. and Ikehara,Y.
    Intracellular processing of complement pro-C3 and proalbumin is inhibited by rat alpha 1-protease inhibitor variant (Met352-->Arg) in transfected cells
    Biochem Biophys Res Commun171, 236-242. PubMed  Europe PubMed DOI
  332. Suzuki,Y., Yoshida,K., Ichimiya,T., Yamamoto,T. and Sinohara,H.
    Trypsin inhibitors in guinea pig plasma: isolation and characterization of contrapsin and two isoforms of alpha-1-antiproteinase and acute phase response of four major trypsin inhibitors
    J Biochem107, 173-179. PubMed  Europe PubMed
  333. 1989
  334. Engh,R., Lobermann,H., Schneider,M., Wiegand,G., Huber,R. and Laurell,C.B.
    The S variant of human alpha1-antitrypsin, structure and implications for function and metabolism
    Protein Eng2, 407-415. PubMed  Europe PubMed  S
  335. Huber,R. and Carrell,R.W.
    Implications of the three-dimensional structure of alpha1- antitrypsin for structure and function of serpins
    Biochemistry28, 8951-8966. PubMed  Europe PubMed  S
  336. 1988
  337. Banda,M.J., Rice,A.G., Griffin,G.L. and Senior,R.M.
    Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase
    J Biol Chem263, 4481-4484. PubMed  Europe PubMed
  338. Conlan,J.W., Williams,A. and Ashworth,L.A.
    Inactivation of human alpha-1-antitrypsin by a tissue-destructive protease of Legionella pneumophila
    J Gen Microbiol134, 481-487. PubMed  Europe PubMed
  339. 1987
  340. Banda,M.J., Clark,E.J., Sinha,S. and Travis,J.
    Interaction of mouse macrophage elastase with native and oxidized human alpha 1-proteinase inhibitor
    J Clin Invest79, 1314-1317. PubMed  Europe PubMed DOI
  341. 1986
  342. Heidtmann,H. and Travis,J.
    Human alpha1-proteinase inhibitor
    [ISSN:0-444-80763-2] (1986) 441-456.
  343. Johnson,D.A., Barrett,A.J. and Mason,R.W.
    Cathepsin L inactivates alpha1-proteinase inhibitor by cleavage in the reactive site region
    J Biol Chem261, 14748-14751. PubMed  Europe PubMed
  344. Schapira,M., Ramus,M.A., Jallat,S., Carvallo,D. and Courtney,M.
    Recombinant alpha1-antitrypsin Pittsburgh (Met 358->Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment
    J Clin Invest77, 635-637. PubMed  Europe PubMed DOI  M
  345. Scott,C.F., Carrell,R.W., Glaser,C.B., Kueppers,F., Lewis,J.H. and Colman,R.W.
    Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf
    J Clin Invest77, 631-634. PubMed  Europe PubMed DOI
  346. 1985
  347. [YEAR:24-10-1985]Carrell,R.W. and Owen,M.C.
    Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis
    Nature317, 730-732. PubMed  Europe PubMed
  348. [YEAR:10-1-1985]Courtney,M., Jallat,S., Tessier,L.H., Benavente,A., Crystal,R.G. and Lecocq,J.P.
    Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosis
    Nature313, 149-151. PubMed  Europe PubMed  E
  349. [YEAR:16-1-1985]Laurent,P. and Bieth,J.G.
    Cigarette smoke decreases the rate constant for the association of elastase with alpha 1-proteinase inhibitor by a non-oxidative mechanism
    Biochem Biophys Res Commun126, 275-281. PubMed  Europe PubMed
  350. [YEAR:10-4-1985]Travis,J., Owen,M., George,P., Carrell,R., Rosenberg,S., Hallewell,R.A. and Barr,P.J.
    Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor
    J Biol Chem260, 4384-4389. PubMed  Europe PubMed
  351. 1984
  352. [YEAR:19-11-1984]Bathurst,I.C., Travis,J., George,P.M. and Carrell,R.W.
    Structural and functional characterization of the abnormal Z alpha 1-antitrypsin isolated from human liver
    FEBS Lett177, 179-183. PubMed  Europe PubMed DOI
  353. Beatty,K., Matheson,N. and Travis,J.
    Kinetic and chemical evidence for the inability of oxidized alpha 1-proteinase inhibitor to protect lung elastin from elastolytic degradation
    Hoppe Seylers Z Physiol Chem365, 731-736. PubMed  Europe PubMed
  354. Bruce,R.M., Cohen,B.H., Diamond,E.L., Fallat,R.J., Knudson,R.J., Lebowitz,M.D., Mittman,C., Patterson,C.D. and Tockman,M.S.
    Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects
    Am Rev Respir Dis130, 386-390. PubMed  Europe PubMed
  355. Cox,D.W. and Billingsley,G.D.
    Oxidation of plasma alpha 1-antitrypsin in smokers and nonsmokers and by an oxidizing agent
    Am Rev Respir Dis130, 594-599. PubMed  Europe PubMed
  356. [YEAR:23-6-1984]Eriksson,S.
    Alpha 1-antitrypsin deficiency: some personal experiences
    Schweiz Med Wochenschr114, 893-894. PubMed  Europe PubMed
  357. [YEAR:12-3-1984]Foreman,R.C., Judah,J.D. and Colman,A.
    Xenopus oocytes can synthesise but do not secrete the Z variant of human alpha 1-antitrypsin
    FEBS Lett168, 84-88. PubMed  Europe PubMed
  358. Fuchs,H.E., Michalopoulos,G.K. and Pizzo,S.V.
    Hepatocyte uptake of alpha 1-proteinase inhibitor-trypsin complexes in vitro: evidence for a shared uptake mechanism for proteinase complexes of alpha 1-proteinase inhibitor and antithrombin III
    J Cell Biochem25, 231-243. PubMed  Europe PubMed DOI
  359. [YEAR:22-12-1984]George,P.M., Vissers,M.C., Travis,J., Winterbourn,C.C. and Carrell,R.W.
    A genetically engineered mutant of alpha 1-antitrypsin protects connective tissue from neutrophil damage and may be useful in lung disease
    Lancet2, 1426-1428. PubMed  Europe PubMed
  360. [YEAR:10-6-1984]Gitel,S.N., Medina,V.M. and Wessler,S.
    Inhibition of human activated factor X by antithrombin III and alpha 1-proteinase inhibitor in human plasma
    J Biol Chem259, 6890-6895. PubMed  Europe PubMed
  361. [YEAR:13-9-1984]Hill,R.E., Shaw,P.H., Boyd,P.A., Baumann,H. and Hastie,N.D.
    Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions
    Nature311, 175-177. PubMed  Europe PubMed
  362. Hirano,K., Okumura,Y., Hayakawa,S., Adachi,T. and Sugiura,M.
    Inhibition of human tissue kallikrein by alpha 1-proteinase inhibitor
    Hoppe Seylers Z Physiol Chem365, 27-32. PubMed  Europe PubMed
  363. [YEAR:8-3-1984]Kidd,V.J., Golbus,M.S., Wallace,R.B., Itakura,K. and Woo,S.L.
    Prenatal diagnosis of alpha 1-antitrypsin deficiency by direct analysis of the mutation site in the gene
    N Engl J Med310, 639-642. PubMed  Europe PubMed DOI
  364. Loebermann,H., Tokuoka,R., Deisenhofer,J. and Huber,R.
    Human alpha1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function
    J Mol Biol177, 531-557. PubMed  Europe PubMed  S
  365. [YEAR:9-10-1984]Long,G.L., Chandra,T., Woo,S.L., Davie,E.W. and Kurachi,K.
    Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant
    Biochemistry23, 4828-4837. PubMed  Europe PubMed
  366. Morihara,K., Tsuzuki,H., Harada,M. and Iwata,T.
    Purification of human plasma alpha 1-proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase
    J Biochem95, 795-804. PubMed  Europe PubMed
  367. Neumann,S., Gunzer,G., Hennrich,N. and Lang,H.
    "PMN-elastase assay": enzyme immunoassay for human polymorphonuclear elastase complexed with alpha 1-proteinase inhibitor
    J Clin Chem Clin Biochem22, 693-697. PubMed  Europe PubMed
  368. [YEAR:1-11-1984]Rosenberg,S., Barr,P.J., Najarian,R.C. and Hallewell,R.A.
    Synthesis in yeast of a functional oxidation-resistant mutant of human alpha-antitrypsin
    Nature312, 77-80. PubMed  Europe PubMed  E
  369. [YEAR:10-7-1984]Tanaka,T., Ohkubo,H. and Nakanishi,S.
    Common structural organization of the angiotensinogen and the alpha 1-antitrypsin genes
    J Biol Chem259, 8063-8065. PubMed  Europe PubMed
  370. [YEAR:23-6-1984]Virca,G.D. and Schnebli,H.P.
    The elastase/alpha 1-proteinase inhibitor balance in the lung. A review
    Schweiz Med Wochenschr114, 895-898. PubMed  Europe PubMed
  371. Wyss,A., Virca,G.D. and Schnebli,H.P.
    Cigarette smoke components are not very effective in directly inactivating alpha 1-proteinase inhibitor
    Hoppe Seylers Z Physiol Chem365, 511-516. PubMed  Europe PubMed
  372. 1983
  373. [YEAR:21-3-1983]Bathurst,I.C., Stenflo,J., Errington,D.M. and Carrell,R.W.
    Translation and processing of normal (PiMM) and abnormal (PiZZ) human alpha 1-antitrypsin
    FEBS Lett153, 270-274. PubMed  Europe PubMed DOI
  374. [YEAR:28-4-1983]Boswell,D.R., Jeppsson,J.O., Brennan,S.O. and Carrell,R.W.
    The reactive site of alpha 1-antitrypsin is C-terminal, not N-terminal
    Biochim Biophys Acta744, 212-218. PubMed  Europe PubMed
  375. Carp,H., Janoff,A., Abrams,W., Weinbaum,G., Drew,R.T., Weissbach,H. and Brot,N.
    Human methionine sulfoxide-peptide reductase, an enzyme capable of reactivating oxidized alpha-1-proteinase inhibitor in vitro
    Am Rev Respir Dis127, 301-305. PubMed  Europe PubMed
  376. [YEAR:25-10-1983]Chandra,T., Stackhouse,R., Kidd,V.J., Robson,K.J. and Woo,S.L.
    Sequence homology between human alpha 1-antichymotrypsin, alpha 1-antitrypsin, and antithrombin III
    Biochemistry22, 5055-5061. PubMed  Europe PubMed
  377. Idell,S. and Cohen,A.B.
    Alpha-1-antitrypsin deficiency
    Clin Chest Med4, 359-375. PubMed  Europe PubMed
  378. [YEAR:21-7-1983]Kidd,V.J., Wallace,R.B., Itakura,K. and Woo,S.L.
    alpha 1-antitrypsin deficiency detection by direct analysis of the mutation in the gene
    Nature304, 230-234. PubMed  Europe PubMed
  379. Lai,E.C., Kao,F.T., Law,M.L. and Woo,S.L.
    Assignment of the alpha 1-antitrypsin gene and a sequence-related gene to human chromosome 14 by molecular hybridization
    Am J Hum Genet35, 385-392. PubMed  Europe PubMed
  380. [YEAR:22-9-1983]Owen,M.C., Brennan,S.O., Lewis,J.H. and Carrell,R.W.
    Mutation of antitrypsin to antithrombin: alpha 1-antitrypsin Pittsburgh (358 Met to Arg), a fatal bleeding disorder
    N Engl J Med309, 694-698. PubMed  Europe PubMed DOI
  381. 1982
  382. Carp,H., Miller,F., Hoidal,J.R. and Janoff,A.
    Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity
    Proc Natl Acad Sci U S A79, 2041-2045. PubMed  Europe PubMed
  383. [YEAR:22-7-1982]Carrell,R.W., Jeppsson,J.O., Laurell,C.B., Brennan,S.O., Owen,M.C., Vaughan,L. and Boswell,D.R.
    Structure and variation of human alpha 1-antitrypsin
    Nature298, 329-334. PubMed  Europe PubMed
  384. [YEAR:1-11-1982]Errington,D.M., Bathurst,I.C., Janus,E.D. and Carrell,R.W.
    In vitro synthesis of M and Z forms of human alpha 1-antitrypsin
    FEBS Lett148, 83-86. PubMed  Europe PubMed DOI
  385. [YEAR:24-6-1982]Leicht,M., Long,G.L., Chandra,T., Kurachi,K., Kidd,V.J., Mace,M., Jr., Davie,E.W. and Woo,S.L.
    Sequence homology and structural comparison between the chromosomal human alpha 1-antitrypsin and chicken ovalbumin genes
    Nature297, 655-659. PubMed  Europe PubMed
  386. Lobermann,H., Lottspeich,F., Bode,W. and Huber,R.
    Interaction of human alpha1-proteinase inhibitor with chymotrypsinogen A and crystallization of a proteolytically modified alpha1-proteinase inhibitor
    Hoppe Seylers Z Physiol Chem363, 1377-1388. PubMed  Europe PubMed
  387. Tobin,M.J. and Hutchison,D.C.
    An overview of the pulmonary features of alpha 1-antitrypsin deficiency
    Arch Intern Med142, 1342-1348. PubMed  Europe PubMed DOI  M
  388. [YEAR:4-3-1982]Vaughan,L., Lorier,M.A. and Carrell,R.W.
    alpha 1-Antitrypsin microheterogeneity. Isolation and physiological significance of isoforms
    Biochim Biophys Acta701, 339-345. PubMed  Europe PubMed
  389. [YEAR:4-6-1982]Virca,G.D., Lyerly,D., Kreger,A. and Travis,J.
    Inactivation of human plasma alpha 1-proteinase inhibitor by a metalloproteinase from Serratia marcescens
    Biochim Biophys Acta704, 267-271. PubMed  Europe PubMed
  390. 1981
  391. [YEAR:30-11-1981]Chandra,T., Kurachi,K., Davie,E.W. and Woo,S.L.
    Induction of alpha 1-antitrypsin mRNA and cloning of its cDNA
    Biochem Biophys Res Commun103, 751-758. PubMed  Europe PubMed
  392. [YEAR:10-4-1981]Clark,R.A., Stone,P.J., El Hag,A., Calore,J.D. and Franzblau,C.
    Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils
    J Biol Chem256, 3348-3353. PubMed  Europe PubMed
  393. Gadek,J.E., Klein,H.G., Holland,P.V. and Crystal,R.G.
    Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects
    J Clin Invest68, 1158-1165. PubMed  Europe PubMed
  394. Kurachi,K., Chandra,T., Degen,S.J., White,T.T., Marchioro,T.L., Woo,S.L. and Davie,E.W.
    Cloning and sequence of cDNA coding for alpha1-antitrypsin
    Proc Natl Acad Sci U S A78, 6826-6830. PubMed  Europe PubMed
  395. Travis,J. and Johnson,D.
    [55] Human alpha1-proteinase inhibitor
    Methods Enzymol80, 754-765. DOI
  396. 1980
  397. Banda,M.J., Clark,E.J. and Werb,Z.
    Limited proteolysis by macrophage elastase inactivates human alpha1-proteinase inhibitor
    J Exp Med152, 1563-1570. PubMed  Europe PubMed
  398. Brodrick,J.W., Glaser,C.B., Largman,C., Geokas,M.C., Graceffo,M., Fassett,M. and Maeda,H.
    Interaction of chymotrypsinogens with alpha1-protease inhibitor
    Biochemistry19, 4865-4870. PubMed  Europe PubMed
  399. Carrell,R.W., Boswell,D.R., Brennan,S.O. and Owen,M.C.
    Active site of alpha1-antitrypsin: homologous site in antithrombin-III
    Biochem Biophys Res Commun93, 399-402. PubMed  Europe PubMed
  400. Mahoney,W.C., Kurachi,K. and Hermodson,M.A.
    Formation and dissociation of the covalent complexes between trypsin and two homologous inhibitors, alpha 1-antitrypsin and antithrombin III
    Eur J Biochem105, 545-552. PubMed  Europe PubMed
  401. [YEAR:10-5-1980]Mega,T., Lujan,E. and Yoshida,A.
    Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. II. Structure of oligosaccharides
    J Biol Chem255, 4057-4061. PubMed  Europe PubMed
  402. [YEAR:16-10-1980]Wong,P.S. and Travis,J.
    Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluid
    Biochem Biophys Res Commun96, 1449-1454. PubMed  Europe PubMed
  403. 1979
  404. [YEAR:14-12-1979]Carrell,R., Owen,M., Brennan,S. and Vaughan,L.
    Carboxy terminal fragment of human alpha-1-antitrypsin from hydroxylamine cleavage: homology with antithrombin III
    Biochem Biophys Res Commun91, 1032-1037. PubMed  Europe PubMed
  405. [YEAR:10-9-1979]Hodges,L.C., Laine,R. and Chan,S.K.
    Structure of the oligosaccharide chains in human alpha 1-protease inhibitor
    J Biol Chem254, 8208-8212. PubMed  Europe PubMed
  406. [YEAR:25-5-1979]Johnson,D. and Travis,J.
    The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center
    J Biol Chem254, 4022-4026. PubMed  Europe PubMed
  407. [YEAR:25-6-1979]Kress,L.F., Kurecki,T., Chan,S.K. and Laskowski,M., Sr.
    Characterization of the inactive fragment resulting from limited proteolysis of human alpha1-proteinase inhibitor by Crotalus adamanteus proteinase II
    J Biol Chem254, 5317-5320. PubMed  Europe PubMed
  408. [YEAR:28-5-1979]Matheson,N.R., Wong,P.S. and Travis,J.
    Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase
    Biochem Biophys Res Commun88, 402-409. PubMed  Europe PubMed
  409. Morihara,K., Tsuzuki,H. and Oda,K.
    Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor
    Infect Immun24, 188-193. PubMed  Europe PubMed
  410. 1978
  411. Bloom,J.W. and Hunter,M.J.
    Interactions of alpha1-antitrypsin with trypsin and chymotrypsin
    J Biol Chem253, 547-559. PubMed  Europe PubMed
  412. Carp,H. and Janoff,A.
    Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants
    Am Rev Respir Dis118, 617-621. PubMed  Europe PubMed
  413. [YEAR:25-10-1978]Johnson,D. and Travis,J.
    Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor
    J Biol Chem253, 7142-7144. PubMed  Europe PubMed
  414. Kress,L.F. and Paroski,E.A.
    Enzymatic inactivation of human serum proteinase inhibitors by snake venom proteinases
    Biochem Biophys Res Commun83, 649-656. PubMed  Europe PubMed
  415. 1977
  416. [YEAR:1-6-1977]Johnson,D. and Travis,J.
    Inactivation of human alpha 1-proteinase inhibitor by thiol proteinases
    Biochem J163, 639-641. PubMed  Europe PubMed
  417. 1976
  418. [YEAR:26-11-1976]Owen,M.C., Carrell,R.W. and Brennan,S.O.
    The abnormality of the S variant of human alpha-1-antitrypsin
    Biochim Biophys Acta453, 257-261. PubMed  Europe PubMed
  419. Pierce,J.A., Jeppsson,J.O. and Laurell,C.B.
    alpha-1 Antitrypsin phenotypes determined by isoelectric focusing of the cysteine-antitrypsin mixed disulfide in serum
    Anal Biochem74, 227-241. PubMed  Europe PubMed
  420. Yoshida,A., Lieberman,J., Gaidulis,L. and Ewing,C.
    Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency
    Proc Natl Acad Sci U S A73, 1324-1328. PubMed  Europe PubMed
  421. 1974
  422. Johnson,D.A., Pannell,R.N. and Travis,J.
    The molecular stoichiometry of trypsin inhibition by human alpha-1-proteinase inhibitor
    Biochem Biophys Res Commun57, 584-589. PubMed  Europe PubMed
  423. [YEAR:7-7-1974]Moroi,M. and Yamasaki,M.
    Mechanism of interaction of bovine trypsin with human alpha1-antitrypsin
    Biochim Biophys Acta359, 130-141. PubMed  Europe PubMed
  424. Pannell,R., Johnson,D. and Travis,J.
    Isolation and properties of human plasma alpha-1-proteinase inhibitor
    Biochemistry13, 5439-5445. PubMed  Europe PubMed
  425. Sandhaus,R.A. and Janoff,A.
    Degradation of human alpha1 antitrypsin by hepatocyte acid cathepsins. Possible role in clinical alpha1 antitrypsin deficiency
    Am Rev Respir Dis110, 263-272. PubMed  Europe PubMed
  426. 1973
  427. Kueppers,F.
    Alpha1-antitrypsin
    Am J Hum Genet25, 677-686. PubMed  Europe PubMed
  428. 1972
  429. Janoff,A.
    Inhibition of human granulocyte elastase by serum alpha-1-antitrypsin
    Am Rev Respir Dis105, 121-122. PubMed  Europe PubMed
  430. [YEAR:7-1-1972]Lieberman,J., Mittman,C. and Gordon,H.W.
    Alpha 1 antitrypsin in the livers of patients with emphysema
    Science175, 63-65. PubMed  Europe PubMed
  431. 1969
  432. Sharp,H.L., Bridges,R.A., Krivit,W. and Freier,E.F.
    Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder
    J Lab Clin Med73, 934-939. PubMed  Europe PubMed  M
  433. 1966
  434. Briscoe,W.A., Kueppers,F., Davis,A.L. and Bearn,A.G.
    A case of inherited deficiency of serum alpha-antitrypsin associated with pulmonary emphysema
    Am Rev Respir Dis94, 529-539. PubMed  Europe PubMed  M
  435. 1965
  436. Laurell,C.B.
    Genetic variants of alpha1-antitrypsin
    Vox Sang10, 363-364. PubMed  Europe PubMed
  437. 1964
  438. [YEAR:25-12-1964]Kueppers,F., Briscoe,W.A. and Bearn,A.G.
    Hereditary deficiency of serum alpha1-antitrypsin
    Science146, 1678-1679. PubMed  Europe PubMed
  439. 1962
  440. [YEAR:15-4-1962]Schultze,H.E., Heide,K. and Haupt,H.
    [alpha1-Antitrypsin from human serum]
    Klin Wochenschr40, 427-429. PubMed  Europe PubMed
  441. 1953
  442. Peanasky,R.J. and Laskowski,M.
    Partial purification of the trypsin inhibitor from blood plasma
    J Biol Chem204, 153-157. PubMed  Europe PubMed